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ABSTRACT 
Cervical carcinoma is the fourth most common malignancy worldwide and fourth 
most common cause of deaths due to cancer worldwide which makes it an 
important public health problem. The cellular changes in cervix and intraepithelial 
lesions can be detected many years before the patients present with frank invasive 
carcinoma. So, cervical screening programs were introduced worldwide. For many 
years , Conventional PAP smears were used for screening. Though it led to drastic 
reduction in number of cervical carcinoma cases, it had high false negativity. So, 
newer methods like Liquid based cytology were introduced.  This study was 
undertaken to compare Liquid based cytology with Conventional PAP smear and 
to correlate the results with biopsy obtained from the same patient. This study was 
done on randomly selected 100 patients attending the Pilot screening project at 
Department of Obstetrics and Gynaecology , Thanjavur medical college , 
Thanjavur and their personal details like age , puberty age , number of children and 
their presenting complaints were obtained. The sample for Conventional PAP 
smear was taken using Ayre’s spatula and slide prepared. Sample for Liquid based 
Cytology was taken using the Cytobrush and the sample was rinsed in the fixative 
provided by the manufacturer. The sample was then centrifuged and slide prepared. 
Both the slides were then stained using the Rapid PAP stain. Colposcopy was done 
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and biopsy was taken from the suspicious area which was then processed and 
stained by Haematoxylin and Eosin. The slides were analysed and the following 
results were obtained. Most of the patients who attended the screening program 
were in the fourth decade of life. Dysplasia was diagnosed in 26% of cases and 
most were in the age group of 21 – 40 years. Most of the cases were in the Socio 
economic Class II of the Modified Prasad’s classification. Dysplasia was found 
more in the Socio economic class III(12% of cases). 90% of cases started sexual 
activity before 25 years of age and out of these 90 patients,92.3% had dysplasia.  
Dysplasia was more in patients with parity 3(14% of cases). 46% of cases 
presented with white discharge per vaginum. Cytological abnormality was found in 
28 cases (28%) by LBC, whereas conventional Pap smear detected abnormality in 
only 22 cases (22%). 96 cases (96 %) were satisfactory for evaluation on LBC and 
92 cases (92%) on conventional Pap smear. ASC was found in 12% of cases in 
Conventional PAP whereas it was detected in only 6% of cases in LBC. LSIL and 
HSIL was found in 8% and 2% of cases in conventional PAP smear whereas it was 
found in 12% and  8% of cases in LBC. No carcinoma was found in Conventional 
PAP smear whereas 2% of cases had carcinoma features in LBC. Sensitivity and 
specificity of PAP smear in detecting LSIL was 40% and 93% whereas for HSIL it 
is 50% and 100%. Sensitivity and specificity of LBC in detecting LSIL is 66% and 
94% whereas for HSIL it was 100% and 96%. Overall sensitivity and specificity 
3 
 
for Conventional PAP smear is 55.5% and 83.7% whereas for LBC it is 83% and 
86.5% respectively. Statistically, LBC and histopathology was highly correlated     
( r = 0.617)  whereas only medium level of correlation was found for Conventional 
PAP smear (r = 0.4651). 
 
So, Liquid based cytology is strongly advocated in the best interest of public health 
especially in countries like India where more number of people are in the lower 
socioeconomic status category, it improves the sample quality and reduces the 
likelihood of false negative results and hence improving the efficacy of the 
screening programs and thereby reducing the incidence of cervical cancer. 
 
Key Words: Liquid based cytology, conventional Pap smear, cytology. 
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INTRODUCTION 
Cervical carcinoma is the fourth most common malignancy worldwide and 
fourth most common cause of deaths due to cancer worldwide which makes it an 
important public health problem
1
. The cellular changes in cervix and intraepithelial 
lesions can be detected many years before the patients present with frank invasive 
carcinoma
2
. So, cervical screening programs were introduced worldwide. 
 
The introduction of Papanicoloau stain by Dr.Papanicoloau and Traut made 
it possible 
3
. Cervical cancer screening was done using the conventional scrape 
smears stained by papanicoloau stain. This led to drastic reduction in the incidence 
of invasive cervical carcinoma
4
. But CP smears had a high false negative rates . It 
was due to preparation (sampling) errors, presence of blood or mucus (obscuring) 
material, screening and interpretation errors
5
. 
 
In the last 15 years, several cytological techniques were developed to 
improve PAP smear sensitivity. Liquid based cytology was the most important 
development and accepted method. The advantages include removal of obscuring 
cells, mucus and blood, reduction of unsatisfactory smears and inadequate smears, 
provision of cells for detection of HPV, presence of residual sample for performing 
ancillary techniques such as immunocytochemistry. LBC gives standardized slides 
14 
 
containing a monolayer of well stained well preserved cells which is easier to 
interpret than the conventional smears
7
. 
 
So , the aim of this study is to compare the results of conventional PAP 
smear and liquid based preparation and to correlate the results with the 
histopathological findings obtained from  the biopsy. 
  
15 
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AIM OF THE STUDY 
 
1. To study the Conventional PAP smears according to the Bethesda system of 
classification 2001 
 
2. To study the Liquid based preparations according to the Bethesda system of 
classification 2001 
 
3. To study the histopathological findings from the cervix biopsy of the same 
patient 
 
4. To compare the results of Conventional pap smears and Liquid based 
preparations and to correlate with the histopathological findings of the 
cervix biopsy 
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MATERIALS AND METHODS 
This prospective study was conducted at the Department of 
Pathology,Thanjavur medical college,Thanjavur. In our study, we proposed to 
compare Conventional PAP with the new method Liquid based cytology and to 
compare the results with the histopathological examination of the biopsy from the 
same patient. 
The study was conducted on 100 patients selected randomly from patients 
coming for pilot screening project to the department of Obstetrics and 
Gynaecology,Thanjavur medical college. 
Exclusion criteria: 
1. Non co-operative patients. 
2. Patients who do not give consent. 
3. Patients with massive bleeding per vaginum. 
4. Pregnant women. 
5. Treated cervical carcinoma cases. 
After obtaining proper consent, proforma (APPENDIX I) was given to each patient 
and detailed history was obtained. After that, physical examination was done and 
the patient was put in lithotomy position for specimen collection. 
For obtaining the specimens, first for Conventional PAP, Ayer’s spatula was 
inserted into the cervix and gently rotated at 360degree. Then, sample was smeared 
19 
 
onto a grease free slide and fixed in alcohol. After fixation, smear was stained with 
the PAP stain. 
For Liquid based cytology, endocervical brush issued by the manufacturer 
was similarly inserted into the endocervical canal and rotated 360 degrees 3-4 
times. Then, the brush is detached and placed into a vial containing fixative issued 
by the manufacturer for transport. The vial is closed and shaken to obtain a 
homogenous mixing. The vial is taken to the lab where it is again shaken with the 
vortex to obtain a homogenous mixture. After agitation, centrifugal chambers are 
prepared by placing the slide onto the support; the chamber is then placed onto the 
slide and tightened. Into the centrifugal chamber, 2ml of the separator solution 
given by the manufacturer and 5ml of the sample is placed and fixed into a rotor 
and then centrifuged at the rate of 2100rpm/min for 10minutes. After 
centrifugation, liquid is thrown into a container containing disinfectant. Some 
drops of alcohol (100%)are poured along the inner side of cytochamber. The 
chamber is then turned onto a absorbant paper and drained. Then all the parts are 
disassembled and slides are dried before staining. 
After VIA/VILI,biopsy was taken from the doubtful areas. 
 
20 
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Method of staining: 
PAP smear after fixation in alcohol and LBC smears are taken for staining with 
PAP stain(rapid) (APPENDIX II) 
The biopsy specimen obtained was submitted intoto for routine histopathologic 
processing. The tissue sections were stained with Haematoxylin and Eosin 
(APPENDIX III). 
The PAP smears and the LBC slides were examined and  recent 2001 
Bethesda system of classification (APPENDIX IV) were used for reporting. 
Both the reports were correlated with the histopahological report of the biopsy 
which is considered the gold standard. 
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REVIEW OF LITERATURE 
Normal anatomy:
 8
 
It is located in the uterus lower portion. It is cylindrical in shape and the 
length is 2.5 to 3cm and diameter is 2.5 to 3 cm . It consists of two portions:1. 
portio vaginalis 2. portio supravaginalis which is divided according to the vaginal 
reflection. Portio vaginalis outer portion is covered by ectocervix which is lined by 
stratified squamous epithelium and  the endocervical canal is lined by mucin 
producing columnar epithelium. It has two openings external and internal os. 
Squamocolumnar junction is the point at which the ectocervical squamous 
epithelium and endocervical columnar epithelium joins. Transformation zone is the 
zone between the SCJ at puberty and SCJ after squamous metaplasia that occurs as 
the age advances. 
Epithelium of the ectocervix:
8
 
The lining epithelium is nonkeratinising stratified squamous epithelium. It 
consists of superficial, intermediate, parabasal and basal layers. The cells of the 
basal layer has a vertically oriented oval nuclei with a dense chromatin and scanty 
cytoplasm. The cells of this layer are inactive mitotically. Above this layer is the 
parabasal layer .They are larger with large amount of cytoplasm. Mitosis is seen in 
this layer and they express Ki-67. The next layer is the intermediate cell layer. 
These cells have vesicular nuclei and these have abundant and clear cytoplasm due 
24 
 
to glycogen accumulation. The superficial cells have round and small nuclei with a 
clear cytoplasm. There is abundant glycogen in these cells. During menstrual 
cycle, there are changes in the epithelium due to the influence of hormones. 
Superficial cells predominate when there is estrogen in the preovulation stage. In 
the post ovulatory phase, progesterone increases and hence there is predominance 
of intermediate cells. 
Endocervical epithelium and endocervical glands:
8
 
It is covered by a layer of columnar cells  ( mucin producing) .The nucleus is 
basally situated oval small nuclei with dense chromatin.  
Epithelium of the transformation zone:
8
 
                                          Squamous epithelialisation and metaplasia are 
responsible for the endocervical epithelium transformation to squamous 
epithelium. In epithelialisation, mature squamous cells move below the 
endocervical epithelium and push the endocervical cells off the basement 
membrane and there is extension of these process to the clefts. Squamous 
metaplasia is the proliferation and differentiation of the endocervical reserve cells 
to the squamous cells. The reserve cells initially look like parabasal and basal cells. 
When these cells acquire cytoplasm,they are called as immature squamous 
metaplasia. When these cells acquire glycogen, they are called as mature 
25 
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squamous metaplasia. The nuclei of these cells are uniform, smooth contours 
and nuclear abnormalities are minimal. 
Cervical stroma:
8
 
It consists of a denser fibrous stroma admixed with 10 to 15% of the elastin 
and smooth muscle fibres.  Many blood vessels and lymphocytes are seen. 
Changes associated with pregnancy:
8
 
Immature squamous metaplasia and decidual reaction can be seen in 
pregnancy. 
Incidence: 
Cervical cancer is the fourth most common cause of malignancy worldwide 
and it is also the fourth most common cause of cancer deaths according to latest 
cancer statistics issued by International agency for research on cancer (WHO). 
According to the report, 528000 new cases are identified every year and 266000 
cancer deaths are due to cervical cancer. Every 1/5
th
 case of cancer is due to 
cervical cancer
1
. 
According to a review article on the magnitude of cancer cervix in India 
published by A.Nandakumar et. al, age associated incidence rates per 100000 
women is 22.8% in 2004-05 and cancer cervix accounted for 16% of all cancer 
cases in the urban registries of ICMR. 90708 new cases are identified on an 
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average every year. In the hospital based registries cancer cervix is the leading 
cause of death in the urban and rural registries
9
. 
Etiology: 
HPV continues to be the most common etiology for cervical cancers.HPV 
types most common are types 16,18,45,31,33,52,58 and 35
10
. High risk types  are 
16,18,31,33,35,39,45,51,52,56,58,59,68,73 and 82, low risk types are 
6,11,40,42,43,44,54,61,70,72,81 and CP6108. HPV 16 and 18 are strongly 
associated with CIN III and invasive cervical cancer
11
. According to sherman et al, 
93% of tumours expressed HPV DNA.HPV 16 was found in 50%,HPV 14 in 
14%,HPV 45 in 8%,HPV 31 in 5% of specimens. HPV 16 predominated in 
squamous cell carcinomas(51% of  such specimens),HPV 18 predominated in 
adenocarcinomas(56% of such specimens) and adenosquamous tumours(39% of  
such specimens)
12
. Multiparity and younger age of having first child is associated 
with cervical cancer. According to a study conducted by Louise et al,risk rose to 
5.1 (95% confidence interval 2.7–9.7) for those with 14 or more pregnancies13.Oral 
contraceptive usage had more incidence of invasive cancer than the the IUD’s14. 
Cervical cancer is associated with long duration smoking
15
. According to latest 
WHO report, 70% of  cases are in the areas of low developmental areas
1
. This 
difference is due to lack of access to effective screening and lack of facilities for 
28 
 
early detection and treatment. Genetic susceptibility for cervical cancer is related 
to HLA class II,HLA B7 and DQB1
16
. 
Pathogenesis: 
Transformation zone recedes into the distal endocervical canal as the age 
advances
17
. 
SCC and adenocarcinoma of the cervix accounts for most common 
malignancies normally encountered in the cervix. In this, more than 70% of the 
cervical cancers are due to SCC which develops from the transformation zone 
18,19
.The second most common cause of cervical cancer is adenocarcinoma which 
arises from the endocervical cells
19
.The other types of cancers arising in cervix are 
adenosquamous and other carcinomas or malignancies
19
. 
Precancerous lesion of cervix is known as CIN which is of 3 types.CIN 
1(mild dysplasia), CIN 2(moderate dysplasia),CIN3(severe dysplasia),CIS and 
invasive carcinomas
20
. According to Bethesda system, CIN 1are LSIL and both 
CIN 2 and CIN 3 are combined and put into 1 category as HSIL
21,22
. 
The natural history of cervical cancer is that the precancerous lesions of 
cervix do not progress to invasive cervical cancers suddenly. According to 
Holowaty et al, risk of severe dysplasia developing from mild dysplasia was only 
1% per year but moderate dysplasia progresses to severe dysplasia or worse was 
16% within 2 years and 25% within 5 years. The risk of progression was more 
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within the first 2 years after a dysplastic smear
23
.In another study conducted by 
Arends et al,approximate likelihood of regression is 60%,persistence is 
30%,progression to CIN3 is 10% and progression to invasive cancer is 1%. 
Similarly,corresponding approximations for CIN 2 are 40%,40%,20% and 5 %. 
Likelihood of CIN3 going for regression is 33% and progression to invasive cancer 
is 12%
24
.So,if  the cervical cancer is identified at an early micro invasive cervical 
cancer stage and confirmed by biopsy, it can be treated early and it does not 
present with metastatic disease. Whereas if the patients come with later stages 
treatment becomes difficult and it has a poor outcome
24
. 
Prevention and control of cervical cancer: 
         Owing to the huge burden of cervical cancer, prevention and control of 
cervical cancer becomes important. For this, different methods have been 
developed for the early diagnosis and treatment of the cervical precancerous 
lesions which has led to drastic reduction of the disease burden. 
The screening can be done by several methods including cervical cytology 
(Pap smear and newly developed Liquid based cytology) and VIA or VILI and 
HPV DNA detection. So, awareness should be brought for reducing the incidence 
of cervical cancer worldwide. 
Screening: definition and principle 
30 
 
Screening is to identify specific diseases or a condition among asymptomatic 
individuals
25
. So, screening tests have to be applied on a larger population and  
hence should be convenient , inexpensive ,safe and painless
26
. But the main 
disadvantage of the screening tests are the higher margins of error than the 
diagnostic tests and lesser accuracy. 
Table 1 demonstrates the relationship between screening test parameters and 
screened disease and formula for calculating parameters of screening test.
27,28
 
Screening test Disease present Disease absent 
Positive True positive(A) False positive(B) 
Negative False negative(C) True negative(D) 
 
Sensitivity=proportion of persons with the disease in whom the screening test is 
also positive(A/A+C) 
Specificity=proportion of those without the disease in whom the screening test is 
also negative(D/D+C) 
Positive predictive value=probability of disease in subjects with a positive test 
result(A/A+B) 
31 
 
Negative predictive value=probability of absence of the disease in subjects with a 
negative test result 
Efficacy of the screening test means that the test should be able to diagnose 
a disease earlier that it would be without screening and with sufficient accuracy 
that the screening test will produce less false positive and false negative results. 
Effectiveness of early detection by screening test means that the persons 
with disease who are diagnosed early should have a better clinical outcome than 
those persons who are diagnosed without screening
29
. Screening service offered 
should not do any harm such as wrong diagnosis, False positive screening test 
result ,treatment may do more harm than good, labeling people and false assurance 
due to false negative screening test result
30
. False positive screening test result may 
cause unnecessary anxiety among healthy people and these persons may be 
exposed to risks by exposing the screened persons for further examination
26,28
. The 
screening test has some psychological harms on the people such as anticipated 
discomfort or perception of adverse effects of the screening test, unpleasant 
interactions with health care workers, anxiety over the results of the screening test, 
implications of positive screening test and consequence of labeling the persons as 
sick
29
.The screening test is valuable only if the death of the persons due to disease 
is postponed after early diagnosis. The objective of the screening programs is to 
32 
 
reduce moratality and morbidity and improving the quality of the persons in the 
population
31
.  
Andermann et al
32
 described a criteria for the screening program, 
(APPENDIX V). UK national screening committee
33 
also provided a screening 
program(APPENDIX VI) 
According to an article presented in the American journal of clinical pathology 
on the screening guidelines for cervical cancer the following recommendations 
were proposed according to evidence based systematic review
34
(APPENDIX VII). 
Impact of screening on the morbidity and mortality of cervical cancers: 
After the introduction of screening programs by 1950 and 1960’s and 
cytological investigation through PAP smear, effectiveness of the screening 
program was evaluated through many studies and calculated the reduction in the 
mortality and morbidity from various cancer and mortality registries
35
. A study 
conducted in Nordic countries for time trends in mortality from cervical cancer and 
in relation to the organized screening programs in these countries since 1950s 
which showed a decrease in cumulative mortality between 1965 and 1982. In 
Iceland, the screening program targeted a wider age group, so the decline in 
mortality was about 80% which was the greatest among these 5 countries. Sweden 
and Finland also had nationwide screening programs. So ,the decline in mortality 
was 34% and 50% respectively. Only 40% of the population was covered by 
33 
 
screening programs in Denmark, hence the fall in mortality rate was only 25%. 
Even worse was Norway where only 5% of the population was covered by 
screening program, the fall in mortality was also10%. So this study concluded that 
organized screening programs had a greater impact on the mortality from cervical 
cancers
36
. In Denmark, a high decrease in mortality was observed between ages 30-
59
37
. In Sweden cervical cancer mortality trends in relation to age, calendar period, 
degree of screening programs showed that there was 53% reduction in the 
mortality rates and this was attributable to screening
38
. Cohort studies were done to 
estimate the probability of cervical cancer among screened and unscreened women 
and the age adjusted relative risk in the unscreened and screened women was found 
to be 6
39
.In Finland protective effect of the screening program was found to be 
58% in a National health screening programme
40
.After PAP smear, for shorter 
intervals the protection from the disease is stronger
41
. There are many hurdles for 
the implementation of the screening program .If the screening program is well 
planned and managed and properly monitored and evaluated, program can be much 
more effective
42
.There was decrease in the cervical cancer incidence by 25% and 
mortality by 35% in India due to the screening program through VIA
43
. 
CERVIAL CANCER SCREENING METHODS: 
34 
 
Most commonly used screening method is through cervical cytology which 
is done in asymptomatic populations or in cervical cancer patients who come for 
follow up
44
. This is done using routine PAP test or more improvised LBC. 
Conventional cervical cytology: 
In this, endo and ectocervix samples are taken, smeared onto a glass slide, 
fixed and stained by PAP stain
45
 which reduced the mortality due to cervical 
cancer by more than 50 to 70%
46
 and a false negative rate of 55%
47
. Errors can be 
due to poor sampling, sampling may be nonrepresentative and collected sample 
may be inadequately transferred onto the slide. Various new collection devices 
have enabled sampling of large and representative samples
48
.  Depolymerisation of 
the cervical mucus by chemicals produces monolayer sheets of cells.
49 
 
LBC: 
It is used as an alternative method for CP for improving the utility of the 
cervical specimens and detection. In CP,where the device is discarded, a portion of 
the sample is lost and slide may contain mucus and blood 
50,51
. In LBC, the sample 
is collected in the special cytobrush. Representative samples are collected since the 
tip of the brush is placed into the vial. After removing the blood, mucus and debris, 
homogenous mixture of the sample is placed on the slide to get a monolayer and 
35 
 
stained with PAP. Though the cost of LBC is more, it improves the quality of 
screening by detecting more epithelial abnormality
52,53
. 
There are two types : first and second generation 
First generation Liquid based cytology: 
In mid 1990’s liquid based cytology was introduced and after that many 
different LBC techniques were in use worldwide. Of these, Thin prep and Sure 
path were FDA approved and they were also used for non gynaecologic cytology
54
. 
1. Thin prep method: 
In this method, cervix brushes were used for the collection of the sample 
after which the brush is rinsed in a vial containing preservyt solution ,a methanol 
based preservative and fixative by pressing the brush in the bottom of the vial. 
Next,the specimen is processed in the Thinprep automated processor in which by 
mechanical agitation, mucus and lumps of cells are broken. Then, the preservative 
fluid passes through a filter which has many pores with size designed to trap 
epithelial cells and other contaminants pass through. The membrane filter with the 
epithelial cells are transferred to a glass slide which has a diameter of 20mm. 
Automated stainer the stains the slides. Thin,monolayer like preparation is 
made
55,56
. Studies done for evaluating the efficacy of Thin prep showed that more 
number of adequate smears are made and more number of squamous epithelial 
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lesions are diagnosed
57
.Another study shows that more number of intraepithelial 
lesions are detected than conventional smears.
58
 
2. Sure path method: 
Density gradient is the principle in this method. A broom like device with a 
detachable head is used. Here the vial contains a ethanol based fixative. The 
clumps and mucus are broken through syringe aspiration. By using the density 
gradient centrifugation, inflammatory cells and red blood cells are separated from 
the epithelial cells. Cell pellet formed is resuspended and transferred to a slide with 
13mm circular area
59
. A study done by B.Kirshner et al
60
 showed that there was 
reduced unsatisfactory smears in this method and there was increased detection of 
atypical cells and malignancy. Another study by Maurice Fremont-Smith et al 
(2004)
61
 showed that intraepithelial lesions were detected more in Surepath than 
the conventional smears. 
Staining: 
Thinprep uses an automated staining machine and the procedure is similar to 
conventional smears .In surepath, it is an integral process and cytoplasmic staining 
is different from that of the conventional smears. 
Table 2 depicts the differences between thinprep and surepath methods 
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 THINPREP SUREPATH 
Device for collection Cervex brush.brush rinsed 
in fixative 
Broom like brush.head is 
detached into the vial. 
Fixative Preservecyt fluid-
methanol based fixative 
Cytorich fluid-ethanol 
based fixative 
Vortex Not present Vortex mixed 
Gradient centrifuge Not done Done 
Sedimentation Not done Done 
Filter Used Not used 
Staining Standard automated 
staining 
Integral part of the 
procedure 
Staining protocol Similar to Conventional 
smears 
Cytoplasmic staining is 
different 
Smear area 20mm 13mm 
 
The two LBC methods were compared in few studies. A study by Fang-Hui 
Zhao
62
, showed that cervical cancers were equally detected in both the methods. 
But, unsatisfactory smears were less in Surepath due to better enrichment process 
which removes more mucus and blood than Thin prep. Surepath also provided 
more material for HPV DNA testing. 
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Advantages: 
Representative cells are transferred to slide, unsatisfactory smears are 
reduced, ancillary studies can be done with the residual material, epithelial cells 
can be better evaluated since inflammatory component is greatly reduced, 
interpretation time is reduced because of the smaller area. 
Disadvantages: 
Cost of the procedure is more, requires special equipments, interpretation 
differs from that of the conventional smears. 
 
Second generation liquid based cytology: 
Because of the disadvantages of the first generation, second generation LBC 
was introduced. In this, most of the instruments were eliminated and hence the cost 
is less and is much simpler
63
. 
Liquid prep (LP) system: 
It consists of preservative for the specimen , specimen cleaner ,cell base 
reagent. 
Procedure for specimen collection and processing: 
Mucus is removed using a cotton swab and cervical brush used is inserted 
into the cervical canal and is rotated 3-5 times in clockwise direction. The head of 
the brush is detached into a vial containing 5ml of alcohol based preservative. The 
39 
 
preservative and cervical brush with the specimen is mixed with the vortex and a 
homogenous mixture is made. The entire content of the fixative vial is poured into 
a tube containing 4ml of the cleaning solution which is then centrifuged at 1000g 
for 10mins.The work of the cleaning solution is to separate mucus and blood from 
the cells. After discarding the supernatant, to the cell pellet,cell base is added(4-5 
times of cell button) and suspended by mixing with vortex.Then,50μl of the 
mixture is pippetted and then placed onto a slide in circular motion(15-17mm) 
which are then dried and stained with pap stain
63,64
. 
Studies have been done to show the effectiveness of this system. A study by 
Roghaei et al
65
 showed that LP had 62.4% satisfactory smears compared to 31.9% 
in conventional smears. Another study by Hao deshou et al
64
 showed that LP 
detects more number of intraepithelial lesions than the conventional smears. Study 
by Mahmood khaniki et at 
66
 showed that more adequate samples were found in 
liquiprep than CP. Liquiprep had higher sensitivity than CP. M Tunc Canda et al
67
 
showed that unsatisfactory smears were less in LP and atypical squamous cells. 
HSIL and LSIL were detected more in LP. Different LBC techniques were 
compared by Alves et al
68
 which showed that, in all these methods, cellular 
structure were adequately preserved and one can select the method according to the 
choice and availability. 
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Advantages of LP method are :
69,63,67
 clean background ,the cell structure is 
preserved better,screening time is decreased,cost is less than first generation LBC , 
HPV testing can be done using the residual sample. 
Manual liquid based cytology: 
  In this, processing of smears are done using own laboratory prepared 
fixative and cell encapsulating polymers. Vortex and centrifuge are enough for this 
method
70,71,72,73,74
. Maskem et al
70
 uses alcohol agar solution for this method. A 
blend of nutrient agar, wetting agent linear alcoholic alkoxylate, polyethylene 
glycol, alcohol is mixed together to form a monolayer sheet of cells. Unsatisfactory 
smears were only 0.2% and also there was an increased detection of lesions. 
Assessment of liquid based cytology smears: 
Here, fields to be screened are round shaped and much smaller and hence 
advantageous than conventional smears. 
A. Adequacy criteria for liquid based preparation specimens: 
There should be 5000 well visualized and well preserved squamous cells. Atleast 
10 microscopic fields should be seen before reporting.
75
  
The number of cells required per field = 5000 /(area of preparation/area of field). 
10 well preserved endocervical cells indicate adequate transformation zone.
76 
B. Cell morphology: Slight difference in cell morphology is seen between 
Conventional PAP and LBC 
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1. Clean background is seen in LBC which enables to visualize the cells 
clearly. 
2. Necrotic debris ,blood and fibrin are less in LBC due to special processing 
3. Linging diathesis – fine granules of fibrin, blood and necrotic debris seem to 
hang like a wall paper on the cell and cell structure surface 
4. Due to immediate fixation, nuclear enlargement is less in LBC. There is less 
naked nuclei. 
5. Metaplastic squamous cells look like HSIL due to increased N:C ratio and 
rounding up of the nuclei. But this can be differentiated using N:C ratio 
being less than 50%, chromatin distribution being even and smooth nuclear 
contour.
77 
6. Endometrial cells are larger with more prominent nucleoli and the chromatin 
details are better seen in LBC. It is seen as single cells or in groups with 
bean shaped nuclei and intracytoplasmic vacuoles with a clean background. 
7. Atypical squamous cells – cells favouring SIL but no definitive  qualitative 
and quantitative features
78 
.ASC should be diagnosed with 3 features: 
Squamous differentiation , N:C ratio is increased to about 2-3 times the size 
of the intermediate cells , Minimal hyperchromasia, nuclear irregularity and 
multinuclearity. 
8. ASC-US cells appear similar in both the methods 
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9. In ASC-US Cells are larger and flatter in CS whereas the cells are small but 
the nucleus is 2 to 3 times the size of the neutrophil. 
10. Intermediate and superficial cells are affected in LSIL. Immature cells are 
affected in HSIL. HSIL cells are smaller than LSIL. 
11. Morphology of the cells should be considered for the diagnosis of SCC. 
LBC smears have lower cellularity.
79
  
12. Invasive features and tumour diathesis are difficult to find in LBC80 
Papanicolaou developed a class system for reporting cervical smears: class I 
,absence of atypical or abnormal cells; class II, atypical cytology but no evidence 
of malignancy; class III, cytology suggestive but not conclusive of malignancy; 
class IV, cytology strongly suggestive of malignancy; class V, cytology conclusive 
for malignancy. Later it underwent many changes. In 1960 Dr Ralph richart 
proposed a new term cervical intraepithelial neoplasia which was graded from 
grades 1 to 3. This grading remained for two decades. In 1989 the Bethesda system 
was introduced to standardize the reporting of cervical cytology. This underwent 
many modifications and finally in 2001 Bethesda system(APPENDIX IV) 
recommends a specific format for the cytology report ,starting with an explicit 
statement on the adequacy of the specimen, followed by general categorization and 
an interpretation/result.
21 
THE BETHESDA SYSTEM: 
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Specimen adequacy:
21
 
 In 1988, three categories were proposed “satisfactory,less than 
optimal,unsatisfactory”. The middle category was renamed as “satisfactory but 
limited by…”. In 2001 the middle category was eliminated but this system 
advocates the mentioning of the presence or absence of the transformation zone 
and presence of obscuring elements can be mentioned.  In 1988 and 1991, for 
reporting it as adequate smear, there should be an adequate squamous component. 
Types of preparation and minimal number of cells: (according to 2001 Bethesda 
system) 
LBC: 5000 
CP: 8000-12000 
There should be 10 well preserved endocervical or metaplastic squamous cells. If 
the specimen contains even one abnormal cell, the slide is termed satisfactory. If 
the specimen has more than 75% of the squamous cells obscured by white blood 
cells,blood,drying artifact it is termed as unsatisfactory. When 50% to 75% of the 
cells are obscured, it is termed as satisfactory but partially obscured. Only if all the 
nuclei are devoid of cytoplasm the specimen is termed as unsatisfactory. 
Cytology of normal cervical cells:
81
 
44 
 
Superficial squamous cell: 16to 20µm2,occurs singly and loose clusters, 
polygonal , translucent thin eosinophilic cytoplasm with brownish keratohyaline 
granules ,centrally located  pyknotic nucleus 
Intermediate squamous cells: 35µm , oval or polygonal , basophilic or 
eosinophilic translucent cytoplasm which may show folding , vesicular with fine 
chromatin nulclei 
Herxheimer spirals: Seen in superficial and intermediate squamous cells with a 
spindle shape or can have a cytoplasmic extension or tail containing different types 
of intracytoplasmic filaments. 
Parabasal squamous cells: 50µm2 seen in post menopausal atrophy occurring 
singly ,  oval in shape , Cytoplasm which is opaque,basophilic 
Endocervical glandular cells: columnar , Cytoplasm which is pale,abundant and 
mucinous , Nuclei which is basally situated,vesicular,chromatin which is granular 
and micronuclei seen and ciliated cells. In CP , cells are present singly or can occur 
as monolayered sheets which can give a honeycomb and picket fence appearance. 
In LBC ,  single cells are seen. 
Metaplastic squamous cells: originating from the endocervical columnar 
epithelial reserve cells , 50µm2 , Occuring singly or pavement like sheets, 
polygonal or oval , Cytoplasm  varying with cell maturation, Immature cells  have 
thin and vacuolated,can have extensions in the cytoplasm where as Mature cells 
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have cytoplasm which is eosinophilic or basophilic,waxy and Nuclei which is  
vesicular with granular chromatin. 
Endometrial cells: Exfoliated more in the first 10 to 12 days of the menstrual 
cycle an seen as different size cohesive clusters. Endometrial cells are small 
cells,cuboidal in shape,round nuclei with chromatin clumping with a nucleoli 
which is small. Superficial stromal cells are seen singly or sheets which are loosely 
cohesive and they look like histiocytes. Deep stromal cells are spindle shapes cells 
which occur in loose clusters. Wreaths or exodus are masses of endometrial cells 
and histiocytes. 
During pregnancy(4
th
/5
th
 month), there is increased(80%) intermediate 
squamous cells  due to estrogen and progesterone secretion. The PAP smear may 
show decidual cells which are also seen in persons taking containing progesterone. 
The cells are seen as clusters which have a granular thick cytoplasm with a round 
or oval large nuclei without prominent nucleoli.  
Arias stella cells – large with cytoplasm which is vacuolated and they have 
multiple nuclei which are hyperchromatic and prominent nucleoli. They look like 
clear cell adenocarcinoma cells. 
Cockleburrs – hematoidin crystal arrays with histiocytes surrounding them. They 
are upto 100µm in size most often seen in pregnant women.  
Postpartum  period – basal cells predominate in these smears. 
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Menopause : 
Early – superficial cells predominate(due to nonovulated graffian follicle 
development).Intermediate or parabasal cells predominate as the menopause 
progresses.  
Atrophic vaginitis – parabasal cells are seen. They have enlarged nuclei which 
mimic dysplastic squamous cells. 
Negative for intraepithelial lesion or malignancy: infections and nonneoplastic 
conditions:
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Bacterial infections: 
Gonorrhea: Caused by Neisseria gonnorhoea presenting as purulent discharge 
from the vagina with a burning sensation seen in the cytoplasm of neutrophilis 
confirmed only by bacterial culture 
Bacterial vaginosis: Called as “shift in flora” , presenting as cervico vaginitis with 
characteristic clue cells  present in the filmy background of coccobacilli.Smears 
contain superficial and intermediate cells covered by coccobacilli.False clue cells 
are  squamous cells which are covered by the bacillary organisms 
Actinomycosis: Caused by actinomyces israelii which is a normal commensal of 
the female genital tract , present in patients with IUDs or pessaries, present as foul 
smelling discharge from the vagina which contains sulfur granules. Gupta bodies 
are irregular, thick clusters or bundles of filaments. 
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Granuloma inguinale: Scraping of the ulcerated lesion shows inflammatory 
exudates with vacuolated macrophages which contains Donovan bodies which has 
safety pin shaped organism demonstrated by Giemsa stain. 
Chlamydia trachomatis: Second most common sexually transmitted disease , 
asymptomatic. Sites affected are cervix, uterus and  adnexal structures. Sites 
unaffected  are vulva or vagina. Invades columnar cells of the endocervical region 
which can spread to the fallopian tubes and the endometrium present in 
ntracytoplasmic vacuoles which contains coccoid bodies.50% of patients present 
with follicular cervicitis which contains lymphoid cells.Tingible body 
macrophages are seen. Final diagnosis can be confirmed by molecular testing. 
Viral infections: 
HPV infection: Most common belonging to Papova virus , sexually transmitted 
exclusively , seen mostly in young women.Precancerous lesion is called as CIN.It 
begins as CIN 1 which progresses to CIN 2 and 3 which are higher grades. In some 
persistent HPV infection, it begins as CIN 2 and 3. Average age for CIN is 30 
years and invasive cancer is 45 years. HPV (low risk) types 6 and 11 are 
responsible for condylomas or genital warts , HPV (high risk) types 16 and 18 are 
associated with 70% of cervical cancers. Most of the sexually transmitted women 
contract some type of HPV in their lifetime. So testing for HPV in the routine 
screening is of limited use.  Gardasil ,Cervarix are HPV vaccines. 
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Herpes simplex virus:  Cervix and vagina are the most commonly infected sites 
caused by HSV 1 and 2 presenting as inflammatory epithelial ulcers. Characteristic 
feature is multinucleated giant cells which has nuclear moulding, intranuclear 
inclusions or has chromatic liquefaction and also has ground glass appearance 
mostly seen at the ulcer borders. Commercially available antibodies can be used 
for identification and confirmation 
Cytomegalovirus: Endometrial and endocervical cells are affected with large 
amphophilic or eosinophilic intranuclear inclusions 
Fungal infections: 
Candidiasis: Normally found in the vagina and cervix mostly caused by candida 
albicans , 3 to 7 µm present as yeasts and pseudohyphal forms which are grey 
brown to eosinophilic and they are formed by elongated budding and they have 
constrictions along their length 
Parasitic infection: 
Trichomonas vaginalis: In the lower female genital tract it is the most common 
STD , Pus balls  are found on the dense inflammatory exudates and they are 
collection Trichomonas vaginalis organisms and polymorphonuclear leukocytes. 
Size of the organism is 15 to 30 µm which are pear shaped, round or oval 
cyanophilic organisms, eccentrically located nucleus,vesicular and pale with 
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intracytoplasmic eosinophilic granules. Seen mostly in LBC. Most commonly 
associated infection  is leptothrix with “spaghetti and meat balls” configuration. 
Inflammation associated cellular changes: Changes in squamous cells are seen 
which have cytoplasmic vacuolization or perinuclear halos and nucleus which are 
hyperchromatic , enlarged which have regular contours and with fuzzy or clumped 
chromatin with polymorphonuclear leukocytes in the background. 
Non neoplastic epithelial changes: The squamous epithelium of the cervix are 
under the influence of inflammation, hormonal effects and external physical 
irritation. So,these effects can be seen as hyperplasia, metaplasia and 
keratinisation. 
Reserve cell hyperplasia: Between the basement membrane and columnar cells of 
the endocervical region there are cells called reserve cells which can differentiate 
into squamous or endocervical glandular cells proliferating due to chemical or 
physical irritation. They occur in clusters and very rarely singly. The reserve cells 
have bland oval nuclei and with a illdefined,scant and vacuolated cytoplasm 
Squamous cell metaplasia: Reserve cells proliferate and transform into immature 
squamous cells which occur in sheets or as single cells and cytoplasm of these cells 
is pale and vacuolated. The nuclei of these cells are slightly hyperchromatic oval 
with a fine chromatin and Spider cells are the cytoplasmic extensions or tails of 
these immature cells which can then transform into mature cells. 
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Hyperkeratosis: This is a protective process for injuries seen in prolapse uterus 
seen as layers of anucleated squamous cells are seen in the smears 
Parakeratosis: In this, pyknotic nuclei is retained in the keratinized squamous cells 
which are small round or spindle shaped , occur in loose clusters or as single cells . 
Pseudokeratotic cells are also squamous cells which have basophilic or 
eosinophilic cytoplasm which have oval nonpyknotic nuclei which have 
condylomatous lesions. 
Tubuloendometrial metaplasia: (30% of women). Seen in the deeper clefts of the 
endocervical regions upper portion. Smears show cells which are ciliated and with 
a clear cytoplasm and abundant secretory cells,apical ciliae and intercalated cells 
which have a scanty cytoplasm and long thin nuclei(peg cells) 
Urothelial metaplasia: Seen in atrophic squamous containing  elderly patients. 
These cells have longitudinal grooves and bland oval nuclei 
Reactive cellular changes due to inflammation and repair cells: These changes are 
benign seen in radiation, inflammation, IUD usage and many other nonspecific 
causes 
Repair cells : Seen in inflammatory epithelial ulcers  with history of previous 
biopsy, cryosurgery and cautery of the uterine cervix .They are of glandular or 
squamous in type. Nucleus is 1,1.5,2 times the normal intermediate cell nucleus . 
Double or multiple nucleus may be seen and they have smooth contours with mild 
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hyperchromatism and fine chromatin with single or multiple prominent nucleoli 
and cytoplasm of these cells have polychromasia,perinuclear halo and 
vacuolization without thick rim of cytoplasm. Spider cells are seen. 
Vitamin B12 and folic acid deficiency induced changes: Squamous cells 
enlargement with enlargement of their nuclei which may be  single or double 
nuclei which have fine chromatin and slight hyperchromatism. Pernicious anaemia  
have polymorphonuclear leukocytes have hypersegmented nuclei in the smear 
Radiation and chemotherapy effects:  
Radiation effects: Intracytoplasmic molecules ionization seen due to destruction 
of cellular enzymes and proteins and inhibition of DNA synthesis. Highly 
susceptible cells are the rapidly dividing cells .These changes can be divided into 
acute and chronic 
Acute radiation effects: 
Few days after the completion of treatment, these changes appear which persists 
for about 6 to 8 weeks and then radiation effects gradually subside. Squamous cells 
are affected more than the endocervical cells. The effects are seen as inflammatory 
exudates.Pus balls and repair cells are seen. Nucleus have pallor, vacuolization, 
wrinkling and chromatin smudging with multinucleated/binucleated 
hyperchromatic nuclei with single or multiple prominent nucleoli. Cytoplasm may 
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show hyalinization, vacuolization, polychromasia and intracytoplasmic 
aggregation of  leukocytes. 
Chronic radiation changes: 
Appear late i.e after 6 months of completion of treatment but these changes remain 
for years. There is an atrophic pattern in the smear with intermediate and parabasal 
cells predominating in the smear and pleomorphic giant cells are seen.  
Chemotherapeutic effects: 
Alkylating agents are the most common offending drugs. DNA,RNA and 
proteins are altered by many different mechanisms. These changes are similar to 
those caused by radiation but they are systemic and they are less marked and there 
is less number of cells in PAP smear. 
Benign appearing endometrial cells in women over 40 years of age(1% of smears): 
  In PAP smears these are seen as three dimensional small round clusters. In 
most of the patients these cells are from normal and cycling endometrium and in 
small number of cases, these cells are seen in cases with endometrial polyp and in 
patients using intrauterine devices and in those patients receiving hormone 
replacement therapy. Endometrial hyperplasia and carcinoma are seen in less than 
1% of patients.  
Glandular cells in post hysterectomy PAP smear: 
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The benign glandular cells are similar to the endocervical cells of the cervix 
and seen in patients after total hysterectomy and after postoperative radiotherapy. 
Squamous epithelium of the vagina undergoes glandular or mucinous metaplasia 
and these cells are the glandular cells seen in PAP smear. 
Abnormal shedding of normal appearing endometrial cells: 
Endometrial cells appear in small clusters or groups which have a small oval 
or round bland nucleus and with scant cytoplasm.  
In the premenopausal women,only upto 10 to 12 days of the menstrual cycle the 
endometrial cells appear in the smear.The causes are patients with IUD 
,anovulatory cycle, endometritis, prior uterine endoscopy or endometrial curettage, 
hormonal therapy, endometrial polyp, submucosal fibroid, hyperplasia of the 
endometrium or endometrial carcinoma rarely. 
In post menopausal women,the most important cause for this abnormal 
shedding is hormonal replacement therapy. Second important cause is endometrial 
polyp and others being endometrial hyperplasia and carcinoma. 
Vaginal endometriosis: 
  In smears ,endometrial epithelial fragments,endometrial stromal cell 
clusters, degenerated erythrocytes and  hemosiderin laden  macrophages are seen. 
Vaginal adenosis: 
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Presence of tuboendometrial epithelium or endocervical glandular 
epithelium in the vagina. Upper one third of the anterior vaginal wall is the most 
commonly affected . DES exposure in utero is considered to be an important 
contributing factor. In the smears, benign endocervical glandular cells can occur in 
loose clusters, monolayered sheets or singly. There may also be metaplastic 
squamous cells in the smears. 
IUD induced cellular changes: 
In IUD users there are atypical cellular changes involving the metaplastic 
squamous cells of the cervix and endometrial glandular cells. In smears, 
regenerative and reactive endometrial cells seen in clusters can be seen due to 
mechanical effects. There is enlargement of the cytoplasm in these cells. The 
cytoplasm show vacuolization, prominent  nucleoli which mimic malignant cells of 
the glandular epithelium. The metaplastic squamous cells of the cervix show 
nucleoli which is prominent. The endometrial cells may mimic HSIL/CIN 3 and 
hence they show high N/C ratio, irregular nuclear contours or membrane with 
nuclear hyperchromatism.  
Other cytologic findings: 
Cornflakes – This is a brown artifact and is caused due to xylene deposition 
before application of the coverslip and there is air deposition in the superficial 
squamous cells. 
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Blue blobs – It is condensed mucus, degenerated bare nuclei and  haematoxylin 
precipitation. It represents degenerating intermediate/parabasal cells in post 
menopausal women. They appear in the smear as oval to round dark blue 
amorphous masses. 
Psammoma bodies – They are calcified laminated round bodies which are rarely 
seen in conventional PAP smears.  
Carpet beetle part – It is a contaminant from tampon or cotton application 
Curshmann spirals – They are mucous threads which are inspissated within 
cervical glands or clefts. It has no significance. 
Squamous cell abnormalities:
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Squamous intraepithelial lesions:(SIL) 
These lesions are considered to be the precursor lesions for squamous cell 
carcinoma and these lesions are predominantly seen in the reproductive age group 
women. There are 3 grades in CIN lesions with mild dysplasia in grade 1 and 
moderate and severe dysplasia is grade 2 and 3 respectively. Flat condyloma and 
CIN 1 is equal to LSIL and CIN 2 and 3 or CIS is equal to HSIL. 
LSIL: 
It includes flat condyloma,mild dysplasia and CIN 1. The most important 
cause is infection with low risk and high risk HPV. In PAP smears, it is found only 
56 
 
in 2% of cases. Majority of cases with LSIL in PAP smear have LSIL in cervical 
biopsy but in 18% of the cases have HSIL in cervical biopsy. 
LSIL/flat condyloma: 
Koilocytes are present with dyskaryotic nuclei and they are present in sheets 
or singly. Koilocytes are intermediate and superficial squamous cells which have 
multiple or single hyperchromatic and enlarged nuclei with smudged or granular 
chromatin and their nuclear membrane is irregular. There is a perinuclear halo 
which is a clear space surrounded by thick well defined rim of cytoplasm. This 
halo is caused by perinuclear cytoplasmic microorganelles degeneration which is 
caused by HPV infection. 
LSIL/mild dysplasia/CIN 1: 
In the smears , there are intermediate and superficial squamous cells which 
have hyperchromatic and enlarged nuclei and they have irregular nuclear 
membrane. koilocytes are common and absent  nucleoli. 
HSIL: 
In this category, moderate dysplasia,severe dysplasia,CIS,CIN 2 and 3 are 
included. It is present in about 0.5% in PAP smears. Many of them almost 97% are 
positive for high risk HPV. HSIL lesions if not treated may develop into invasive 
carcinomas. 
CIN II: 
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These are parabasal cells which are seen in sheets or singly. These have well 
defined, thick cytoplasm and their nucleus have hyperchromatic and enlarged 
nucleus with irregular or smooth nuclear membranes. The chromatin is fine or 
coarsely granular and it is evenly distributed. Koilocytic changes are not that 
prominent and they have absent nucleoli. 
CIN III: 
In this category there are 3 histologic patterns: Large cell non keratinizing 
,Keratinizing , Small cell patterns 
Non keratinizing CIN3: 
The cells which are exfoliated are large and show pleomorphism. They have 
abundant,ill defined or well defined cytoplasm. The nucleus is irregular and are 
enlarged and hyperchromatic. The nucleus have a finely or coarsely granular 
chromatin and this chromatin is evenly distributed. These cells are exfoliated in 
syncitial clusters.fragments of epithelium is also seen. They do not have nucleoli 
and the necrotic debri is not seen in the smear background. The smear is composed 
fully of spindle shaped cells very rarely. 
Keratinizing CIN3: 
The smear is composed of spindle shaped cells. These cells have thick,well 
defined orangeophilic cytoplasm with nucleus showing hyperchromatism. Mostly 
they are seen singly and rarely clusters of cells are seen in the smear 
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Small cell CIN 3: 
The cells exfoliated in this type have hyperchromatic nucleus and illdefined scant 
cytoplasm. They are exfoliated in loose clusters or singly. They may or may not 
have nuclear moulding. 
Atypical squamous cells: 
This is seen in about less than 5% in PAP smears.ASC/SIL ratio is 3:1.in 
about 10 to 20% of cases,patients who are diagnosed as having ASC have CIN in 
colposcopy directed biopsy. This includes 2 categories:  ASC – US and ASC – H.       
ASC-US: 
  They are intermediate or superficial in type. The size of the nucleus is 2.5 to 
3 times larger than that of the 35µm
2
 size of the intermediate cells of the squamous 
epithelium. They are bi-nucleated or multinucleated with enlargement and N/C 
ratio is slightly increased. They have irregular chromatin and slight 
hyperchromatism is seen in the nucleus. The nuclear contours are regular. They 
have keratinized orangeophilic or eosinophilic dense cytoplasm and perinuclear 
halo may be seen. ASC-US changes may also be seen in conditions such as 
atypical parakeratosis,atrophic vaginitis and atypical repair. 
ASC-H: ( 5 -10 % of cases) 
They are the metaplastic squamous cells which show nuclear atypia but they 
do not fit into the category of HSIL. These cells are found in small numbers. They 
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are seen in small groups or singly. They can be seen in epithelial fragments and 
less than 10 cells are seen.The cells are polygonal in shape,with squamous 
metaplastic cells size and cytoplasm which is dense. The nuclear size is 1.5 to 2.5 
times the squamous metaplastic cell nuclear size which have irregular nuclear 
membrane and chromatin which are irregular and no nucleoli. These cells have 
increased N/C ratio and is equal that of that of HSIL. There is nuclear polarity loss 
in those cells occurring in epithelial fragments or crowded sheets. The smears have 
vague palisading in the peripheral cells which may mimic cervical AIS. 
Cervical invasive SCC: ( 60 – 80 % of cervical malignancies) 
5
th
 to 6
th
 decade of patients are affected presenting mostly with post coital 
bleeding. 
They are classified into 2 types: Keratinizing and  Non keratinizing SCC . 
These are single cells with cytoplasm which is keratinized. The cells with non 
keratinized cytoplasm are seen in smaller aggregates and also in clusters which 
have prominent nucleoli. Necrotic debris due to tumour diathesis is prominent in 
conventional PAP smears. The necrotic debris is minimal in liquid based 
cytological preparations and is collected at the periphery of the tumour cells known 
as clinging diathesis. 
Cervical microinvasive SCC: 
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 These are single cells with or without keratinisation.These cells occur in 
syncitia,loose clusters, hyperchromatic groups or tissue fragments. The nucleus of 
these cells have nuclear clumping and irregular distribution of chromatin having 
macro or micro nucleoli. 
Other rare variants of cervical SCC are Verrucuous carcinoma , Papillary 
squamous (transitional) cell carcinoma , Lymphoepithelioma like carcinoma , 
Sarcomatous squamous carcinoma. 
Glandular cell abnormalities:  
Multipotential reserve cells in the subcolumnar region is responsible for this 
lesion.The most common one is adenocarcinoma of the endocervical type.  
Cervical AIS: 
It is common in women in their 3 rd or 4
th
 decade. Transformation zone is the most 
commonly involved area in majority of cases. There are 3 types: Endocervical , 
Endometriod , Intestinal. In this,endocervical type is the most common classified 
into well and poorly  differentiated. 
Well differentiated-endocervical type: 
The glandular epithelial cells which are malignant occur in large sheets. The 
columnar cells are crowded with stratification of nuclei which is more prominent at 
the edges of the large sheets.The cytoplasm of the short strips of tumour cells 
extend off the tumour cell sheet edges known as feathering which have nuclear 
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palisading. Tumour cell rosettes are seen. The tumour cells are about two to three 
times that of normal endocervical glandular cells Tthe nucleus of these cells are 
hyperchromatic, enlarged and the nuclear chromatin is coarsely or finely granular 
with absent nucleoli in 50% of cases. 
AIS - intestinal variant: Most commonly seen in association with endocervical 
type. The cells are large and they occur singly, in large epithelial fragments or in 
clusters. Intracytoplasmic vacuoles are seen. The vacuoles contain mucin and these 
cells resemble epithelial cells of the colon 
Atypical glandular cells: 
In this category are cells which are inbetween benign reactive changes and 
AIS and adenocarcinoma. It is divided into 2 types: Atypical glandular cells, NOS 
type and Atypical glandular cells,favour neoplastic . It is again divided into two 
types: endocervical and endometrial types 
Atypical endocervical cells,NOS type: These cells occur in strips or sheets with  
some crowding of cells. The smears have enlarged nucleus and is about 3 to 5 
times that of nucleus of endocervical cells. It has well defined distinct cytoplasm 
and it is abundant. N/C ratio is increased and hyperchromatic nuclei. 
Atypical endocervical cells,favour neoplastic: 
These include cells that do not fit into criteria of  invasive or AIS but fall 
short in some features. The cells are seen in clusters,sheets and strips with  nuclear 
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overlap and crowding . Nucleus are enlarged and hyperchromatic. N/C ratio is 
increased. The cell borders are illdefined with scanty cytoplasm. 
Atypical endometrial glandular cells: Single or rounded clusters of small 
glandular cells are seen with cytoplasm is scant or moderate and some cells have 
cytoplasm which is vacuolated . Nucleus  has irregular membrane and  
hyperchromatic and enlarged and nucleoli is prominent. Chronic 
endometritis,polyp of the endometrium,IUD,endometrial hyperplasia are the 
causes. During menstruation, reactive changes may be seen in normal 
endometrium with enlargement of nucleus and pleomorphism. About 50% of 
women in the postmenopausal age group with atypical endometrial cells have 
endometrial pathology which include atypia or hyperplasia. Tumour diathesis or 
high maturation index of squamous cells also indicates malignancy.  
Invasive cervical adenocarcinoma:  
It is most common in 5
th
 decade of life and 25% of all cases are 
adenocarcinoma. ovarian mucinous or endometriod carcinoma are associated with 
these lesions.HPV 16 and 18,P16,ER and PR are positive in majority of 
adenocarcinomas. The most common type is endocervical mucinous carcinomas. 
The second common type is carcinoma of endometriod type. Very rare types are 
the signet ring adenocarcinoma and intestinal adenocarcinoma. 
Well differentiated cervical adenocarcinoma: 
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It has features similar to that of the AIS endocervical type. 
Moderately differentiated cervical invasive adenocarcinoma: 
In this category,large number of malignant cells are seen and they are seen 
as acini and they form papillary clusters,sheets,balls,rosettes,syncytia or strips. The 
tumour cells are dyscohesive with oval hyperhromatic pleomorphic nuclei.The 
nuclear chromatin is fine or coarsely granular with single or multiple 
macronucleoli. The cytoplasm is ill defined and sometimes vacuolated. In about 
30% of cases,tumour diathesis may be present. 
Poorly differentiated cervical adenocarcinoma: 
Clusters or single malignant glandular cells may be seen in the smear. The 
tumour cells have cytoplasm which is illdefined showing nuclear pleomorphism 
and nucleoli which is prominent. 
Cervical adenocarcinoma variants: 
Glassy cell carcinoma: It is an adenosquamous carcinoma which is poorly 
differentiated and is present in less than 1 to 2% of the cervical smears. It is seen 
more commonly in younger patients (mean age 41). It is positive for HPV 16 and 
18.The patients present with a exophytic bulky mass. The polygonal tumour cells 
occur in masses and nests. The cells have the characteristic glassy cytoplasm with 
an oval nuclei and nucleoli which is prominent. Peripheral blood shows prominent 
eosinophilia. In PAP smears, large malignant cells occur as single cells or in 
64 
 
clusters. They have oval nuclei and nucleoli which is prominent similar to 
squamous cell carcinoma-non keratinizing type. The ground glass cytoplasm  may 
be found in some cells of the smear.  
Adenoid cystic carcinoma: ( 1% of adenocarcinoma patients) 
It is more common in elderly patients presenting with a friable polypoidal 
structure. The tumour cells are small and they occur in clusters,trabeculae and 
cords which have lumens filled with eosinophilic hyaline material. It may be 
admixed with SCC of cervix. It is positive for HPV 16 and it is associated with 
poor prognosis. In PAP smears, smaller cells with scanty cytoplasm and the 
nucleus is small,hyperchromatic and oval.basophilic globules can be seen. 
Minimal deviation adenocarcinoma: There are 3 types: 
Cervical minimal deviation adenocarcinoma,mucinous type. 
It is the most common of the 3 types. It is seen in younger women(32 to 42 years). 
Mostly it is sporadic or sometimes it is preceded by an ovarian mucinous tumour 
with HPV negativity . They are diagnosed at a higher stage and hence associated 
with poor prognosis. An area of poorly or moderately differentiated 
adenocarcinoma may be present adjacent to the tumour. In PAP smear,glandular 
cells occur in clusters or sheets,the nucleus is monomorphic and a nucleoli which 
is small and a clear cytoplasm. Cytoplasm may have tails or extensions. 
Mucinous adenocarcinoma,endometriod type: 
65 
 
These occur in sheets with oval nuclei which is of low grade and there is palisading 
at the free borders. The tumour cells form cell stripes have pseudostratified nuclei 
and form rosettes.   
Mucinous adenocarcinoma-nonspecific type: Not clearly known manifestations. 
Clear cell carcinoma: ( 4% of adenocarcinoma) 
It occurs in older patients but with DES exposure vaginal adenosis develops. 
The patients present with a nodular or ulcerated lesion. There are microcystic, 
tubular,solid and papillary patterns. In PAP smears, epithelial cells are seen in 
irregular clusters or sheets.The tumour cells have a granular eosinophilic to clear 
cytoplasm and hobnail configuration is seen. They have oval nuclei and nucleoli 
which is prominent. 
Villoglandular carcinoma: 
Papillae covered by epithelium is seen with central fibrovascular core. In 
PAP smears, malignant epithelial cells occur in monolayered sheets with nuclear 
crowding and they show folding. They have oval nucleus with hyperchromatism 
and nucleoli is inconspicuous. 
Papillary serous carcinoma : (1% of carcinoma) : It is an aggressive tumour 
with metastasis to pelvic and periaortic lymphnode groups occur early. HPV 
positive cases are seen in young women and older patients are HPV negative. In 
PAP smears,malignant glandular cells are seen in three dimensional clusters or 
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monolayered sheets. Papillary structures are seen with a thin fibrovascular core. 
Malignant epithelial cells cover the papillae. 
HISTOPATHOLOGY: 
8 
Squamous lesions of the uterine cervix: 
Basal cell hyperplasia: There is increased thickness of the parabasal and basal 
layers. There is loss of picket fence appearance with nuclei that are vertically 
oriented,oval and enlarged with normal squamous cell maturation. 
Hyperkeratosis and parakeratosis: 
Chronic irritation causes these changes which can be focal or diffuse. Increase in 
the thickness of the keratin layer is called as hyperkeratosis. Retention of the nuclei 
in the superficial layers is called as parakeratosis. The epithelium has rete edges 
elongation with acanthosis. 
Atrophy: 
It occurs due to hormonal stimulation,there is altered maturation of the squamous 
epithelium which manifests as: 
1. Typical atrophy – thin epithelium,total maturation loss with parabasal and basal 
cells, N/C ratio is increased 
2. Atrophy with partial maturation – the cells have glycogen,enlarged nuclei and 
mitosis 
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3. pseudokoilocytosis – these cells contain cytoplasmic halos but these cells unlike 
koilocytic cells have uniform appearance. Binucleation can be seen with 
hyperchromatic nuclei and size variation. 
HSV cervicitis: 
The biopsy should be taken during infection. There is basal layer nuclei 
homogenisatiom and cytoplasm/nuclear vacuolization in the initial phases. 
Later,intermediate layer is also affected which finally forms bullae which rupture 
and there is formation of ulcers. There is epithelial cell necrosis. The cells which 
are infected have a multiple/single nuclei and ground glass chromatin. 
Reactive and reparative squamous atypia: 
These changes are seen with infections such as Chlamydia,trichomonas and 
candida. The changes are enlargement of nuclei,hyperchromatic/vesicular 
nuclei,spongiosis,variation in shape and size of nuclei. Binucleation and halos in 
the cytoplasm are seen. Ulceration,post erosion,post biopsy leads to reparative 
changes. The changes are atypical nuclei and hence should be differentiated from 
dysplasia. This can be differentiated using Ki 67 and P16. 
Radiation induced atypia: 
The changes occur some years after exposure. Squamous epithelium shows 
cytomegaly and due to swelling of the nucleus and cytoplasm. The cytoplasm 
shows vacuolization,erosion and nucleoli which is prominent. The stroma shows 
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necrosis and edema with leukocyte infiltration. The epithelium becomes atrophic 
and hyalinised collagen and necrotic foci are seen in the stroma by sixth week. 
Reactive fibroblasts,endothelial cell enlargement, blood vessel dilatation which is 
followed by thickening of intima,thrombosis with obliteration of lumen. 
Koilocytosis( LSIL , condyloma): There is three fold variation in the size of the 
nuclei with raisinoid nuclei,nuclear membrane irregularity , darker chromatin . 
Halos/peri nuclear cytoplasmic clearing are seen and nuclear spacing is uneven. 
CIN 1(mild squamous dysplasia/LSIL): 
In this lesion,the lower one third of the epithelium of the cervix is affected. 
Picket fence appearance of the basal cells is lost. The atypia is mild to moderate 
which includes enlargement of the nuclei and size and shape of nucleus variation. 
Chromatin pattern alteration and mitosis are seen. The superficial and intermediate 
cell layers show koilocytosis. 
CIN 2(moderate squamous dyaplasia/HSIL): 
In this category,the mild to moderate atypia changes are seen in the lower 
two thirds of the epithelium. If there is marked atypia in the lower thirds of the 
epithelium,it is also included in this category. 
CIN  3(severe squamous dysplasia/squamous CIS/HSIL): 
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In this category,there is marked to moderate atypia which is seen involving 
full thickness of the epithelium. Distinction between severe squamous dysplasia 
and in situ lesion, flattened superficial layer is seen in in situ lesions. 
Microinvasive squamous carcinoma: (superficially invasive squamous 
carcinoma/squamous carcinoma with superficial invasion) 
Different staging system (society of gynaecologic oncologists and FIGO) is used 
for microinvasive carcinoma. FIGO staging system gives the definition as follows: 
Stage IA: invasive carcinoma diagnosed by microscopic examination, 
macroscopically visible lesions even with superficial invasion is stage IB 
Stage IA1:<3mm of stromal invasion in depth and horizontal spread of <7mm 
Stage IA2: >3mm but <5mm of stromal invasion and horizontal spread of <7mm 
Venous,lymphatic and vascular involvement do not change the classification. 
SGO definition is as follows: “A microinvasive lesion should be defined as one in 
which neoplastic epithelium invades the stroma in one or more places to a depth 
<3mm below the basement membrane of the epithelium and in which lymphatic 
and blood vascular involvement is not demonstrated” 
Features: 
There are neoplastic epithelium  tongues which penetrates through the 
basement membrane of the epithelium. The cells near the focus of invasion is 
differentiated better than the other places( in situ/high grade dyaplasia). The 
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eosinophilic cytoplasm is increased,polarity loss,keratin production occasionally. 
There is ragged border at the invasive foci.There is scalloping at the epithelial and 
stromal junction. The stromal reaction is desmoplastic reaction and 
lymphoplasmacytic infiltrate. Microinvasive carcinoma occurs when the surface 
epithelium shows high grade SIL changes , when the glands show necrosis within 
the lumen , when there is aberrant differentiation to squamous epithelium within 
the epithelium.The measurement of invasion is made at the point of origin in the 
basement membrane to the deepest part of the invasion. 
Recognition of vascular and lymphatic invasion: 
The epithelium which is neoplastic is present within the lymphatic/vascular 
spaces. Invasive squamous carcinoma,usual type: Irregular/ragged malignant nests 
of cells  with eosinophilic cytoplasm in the stroma showing desmoplasia with 
epithelium reduplication extending below the endocervical glands. There is loss of 
polarity of the epithelial lining with pseudogland formation within the tumour cell 
nests with necrosis and debri of keratinous material. Tumour is present adjacent to 
the vessels. 
There are 3 grades according to the degree of differentiation: 
Poorly differentiated, moderately differentiated and well differentiated 
Unusual variants of squamous carcinoma: 
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Verrucuous carcinoma:  The surface has a broad papillae and  invasion has a 
pushing pattern with bulbous nests. The cells have no atypia and the cytoplasm is 
abundant.  
 Squamous carcinomas with a papillary pattern: The cells have a 
basaloid/squamoid which looks like SIL cells or transitional cells with oval nucleus 
perpendicular to the papillae. These cases are associated with recurrences. 
Basaloid squamous carcinoma: There are epithelial cell islands which are 
mitotically active and they have nuclear hyperchromatism and peripheral 
palisading  associated with poor prognosis  
Lymphoepithelioma like carcinoma: Undifferentiated cells are present in 
trabeculae or nests with an inflammatory infiltrate. The cells are polygonal or 
larger with  eosinophilic cytoplasm,vesicular nuclei and nucleoli which is 
prominent. Lymphocytes,eosinophils and plasma cells are present. These cases 
have a good prognosis. 
Spindle cell carcinoma (sarcomatoid carcinoma) : This aggressive tumour have 
spindle cells. Osteoclastic type of giant cells are seen. The spindle cells express 
vimentin and keratin focally and EMA. 
Glandular lesions of the uterine cervix: 
Benign lesions that mimic adenocarcinoma in situ: 
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Reactive atypia: These cells have enlargement of nuclei,nuclear size 
variation,nuclear membrane irregularity and psuedostratification of nuclei. 
Atypical oxyphilic metaplasia: These cells are cuboidal to polygonal cells with 
eosinophilic cytoplasm and nuclear hyperchromatism and multinucleation. 
Cytoplasmic vacuolization,apical snouts are seen. The glands are dilated  lined by 
a single layer of cells with tufting occasionally. 
Endometriosis: There are two forms: deep and superficial. Deep lesion is 
associated with pelvic endometriosis. Superficial lesion is associated with trauma 
to the cervix. Macroscopically, it presents as friable red patches, blebs filled with 
blood and measures upto 2cm. The entire epithelium is sometimes replaced with 
small or medium sized oval or round glands. The glandular epithelium is columnar 
with pesudostratification or single row. It has an elongated or round nuclei and 
even distribution of chromatin. Hyperplastic or secreatory changes may be seen. 
There is inflammation, fragmentation and haemorrhage. Bcl 2 staining is useful for 
diagnosis. 
Intestinal metaplasia: This is a rare metaplasia with globlet cells.This metaplasia 
is associated with in situ or invasive lesions. Atypia and mitosis not seen. 
Benign lesions that mimic invasive adenocarcinoma: 
Microglandular hyperplasia: 
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Reproductive age group women are affected more presenting with 
polyps,friable masses or erosions. These lesions can be localized or multifocal 
which can involve the endocervical glands or the surface epithelium. It is 
composed of variably sized and shaped closely placed glands with little stroma in 
between and inflammation. The glands are lined by mucin producing columnar 
epithelium with vacuoles present sub or supranuclearly with uniform nuclei. 
Squamous metaplasia and hyperplasia of the reserve cells can be present. It can 
have reticular or pseudoinfiltrative pattern and signet ring or hobnail cells or 
hyalinised stroma. 
Lobular endocervical glandular hyperplasia: 
Average age of presentation is 45 years. The patients present with 
discharge,abdominal discomfort or polypoidal mass. There is variably sized round 
glands proliferation in lobules, small cystic lined by mucin producing columnar 
cells with a basally situated bland nuclei. Atypia may be seen in some glands with 
irregular contour. Mitosis may be seen. The stroma is hypercellular with 
inflammatory cells.There is no invasion. 
Diffuse laminar endocervical glandular hyperplasia: 
Mostly seen in premenopausal patients presenting  with mucoid/watery 
discharge. It consists of medium sized abnormally or round shaped glands 
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detached from the stroma. Columnar cells which are mucin producing lines the 
glands. Reactive changes may be seen with or without nflammation. 
Endocervical gland hyperplasia,NOS: Endocervical glands increased. 
Benign lesions mimicking either insitu or invasive adenocarcinoma: 
Tubal,endometriod and tuboendometriod metaplasia: Tubal metaplasia is the 
replacement of the epithelium of the endocervix with ciliated,intercalated cells. It 
usually presents as a polyp or a spongy mucoid material. The glands are medium 
sized with variation in shape and size with bland cells and atypia seen. The stroma 
is hypercellular,myxoid,edematous with focal calcifications.In endometriod 
metaplasia,there is replacement of the epithelium with columnar cells. 
Arias stella reaction: It is more commonly associated with pregnancy and rarely 
in patients who are consuming oral contraceptives. It involves superficial and deep 
glands either focally/extensively (confluent). The cells show enlargement, 
cytoplasmic vacuolization, eosiniphilia, irregular nuclei, hob nailing. Marked 
proliferation of the epithelial cells leads to cribriform and solid pattern and papillae 
with tufting. 
Radiation induced atypia of endocervical epithelium: The changes can be acute 
or chronic. Acutely induced changes are immediately apparent which shows 
epithelial cells swelling and vacuolization, necrosis and edema of the stroma with 
vessel dilatation and infiltration by inflammatory cells. Chronic changes appear 
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late and show the following features – endocervical glands are decreased in 
number with shape and size variation. The cell shape can vary from flat to 
columnar with enlargement seen in the nucleus and cells.Vacuolisation and dense 
eosinophilia seen in the cytoplasm,nuclear membrane is slightly irregular or 
smooth with chromatin can be smudged,dense,vesicular or finely granular . 
Intranuclear eosinophilic inclusions/multi nucleated cells can be rarely seen. The 
stromal cells may show the following changes – edema, 
hyalinization,fibrosis,fibroblasts which are bizarre, myxoid areas, calcifications 
and inflammation. Blood vessels changes include hyalinised intima , sclerosis, 
endothelial cell atypia. There is focal expression of CEA. 
AIS and glandular dysplasia: 
In situ lesions have enlargement of nucleus, stratification, nucleoli(small), 
chromatin which is coarse with increased mitotic activity. Apoptotic bodies are 
seen. It first involves the hyperplastic/distended glands. This lesion involves both 
the endocervical glands and the surface epithelium of the transformation zone. This 
lesion can be seen focally or multifocally with glands showing cribriform pattern 
or tufting. There are various subtypes: clear cell , adenosquamous , endometriod , 
tubal , intestinal , endocervical(most common). The endocervical type has 
decreased mucin and moderate cytoplasm.The globlet cells are seen in intestinal 
type and vacuolated cytoplasm. The glands resemble endometrial glands with 
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pseudostratification in the endometriod type. A mixture of intercalated cells,non 
ciliated and ciliated cells are seen with pseudostratification,enlargement of nuclei 
and with mitotic figures. In the adenosquamous type,there is mixture of glandular 
and squamous cells or with cellular features intermediate inbetween. There is 
cuboidal,polyhedral or flattened cells with eosinophilic to clear cytoplasm. 
Glandular dysplasia is defined as cells having nuclear features inbetween 
atypia in the glandular cells and AIS.  
Superficially invasive adenocarcinoma(microinvasive adenocarcinoma): 
In this, there is invasion into the stroma at more than one place to <3mm below the 
basement membrane without lymphatic/vascular involvement according to SGO. 
According to FIGO, two categories are described – stage IA1 is when there is 
<3mm depth and <7mm width stromal invasion , stage IA2 is when there is >3mm 
depth and <5mm and >7mm stromal invasion. 
Invasive adenocarcinoma,common and uncommon types: 
Adenocarcinoma, usual endocervical type: (80% of adenocarcinoma) 
They are moderately differentiated and they contain eosinophilic 
cytoplasm,apoptosis and mitosis. 
Villoglandular adenocarcinoma: 
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It is seen in premenopausal women and a villoglandular pattern is seen. They 
present with cervical erosion or mass. They have tall thin papillae and short broad 
papillae. It has atypical epithelium. The invasion is seen as branching glands. 
Mucinous adenocarcinoma: They have cells having mucin production. 
Minimal deviation adenocarinoma( adenoma malignum): 
Premenopausal women present with watery to mucoid discharge and 
bleeding from the vagina. The patients have a firm friable mass which may be 
endophytic/ exophytic. There is gland proliferation diffusely which is lined by 
columnar mucin producing cells with basally situated nuclei. The glands show 
branching with angulation. There is perineural,vascular/lymphatic invasion in 
some cases. 
Intestinal type adenocarcinoma,not otherwise specified:  (signet ring cell 
adenocarcinoma and colloid carcinoma). 
These tumours have globlet cells with neuroendocrine and paneth cells. Signet ring 
cell carcinoma is associated with adenosquamous or poorly differentiated 
carcinomas. Mucin pools separate the stroma in the colloid carcinoma. 
Endometriod carcinoma: This shows similar features like that of endometrium. 
The difference of this from the primary endometrial carcinoma is the in situ 
adenocarcinoma lesion, no endometrial tissue and CEA positivity,vimentin,ER and 
P16 negativity. 
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Clear cell carcinoma:  Common in women with inutero exposure to DES. This 
cells are flattened,cuboidal or polygonal with eosinophilic to clear cytoplasm in a 
solid,tubulocystic or papillary patterns. Atypia is marked.    
Serous carcinoma: Common in the age group of 26 to70 years with patients 
presenting with watery discharge and bleeding from the vagina. The patients have 
ulcer or mass in the cervix. It is mixed with other types. The papillary structures 
have stratification, cell detachment, tufting with solid areas. Cytologic atypia is 
marked and mitosis is seen. >2cm size,invasion >10mm.Metastasis to lymph node 
is associated with recurrence. 
Adenosquamous carcinoma: Both glandular and squamous elements seen and is 
associated with bad prognosis.                                                                                                                         
Glassy cell carcinoma: 
One of the poorly differentiated variant of adenosquamous carcinoma which 
occurs in the age group of 30 to 44 years and uterine bleeding is the most common 
presentation. It presents as a bulky mass wit size ranging from 3 to 7 cm. Large 
cells occur in sheets and nests with abundant cytoplasm which is amphophilic to 
eosinophilic and ground glass cytoplasm with a large nuclei and nucleoli. 
Eosinophil and plasma cell infiltration is seen. 
Adenoid basal carcinoma(epithelioma) : It consists of basaloid cells which are 
bland and uniform. The tumour occur as well defined nests which are round with 
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peripheral palisading in the stroma. It is seen most commonly in post menopausal 
women(19-91 years). Mostly it is asymptomatic. Usually,tumour is not visible 
grossly. The cells can be cuboidal,spindled or oval. Squamous metaplasia or glands 
can be seen. Intracytoplasmic vacuoles are due to glycogen. This is benign and no 
metastasis is seen. 
Adenoid cystic carcinoma: Post menopausal women are commonly affected 
presenting with bleeding uterus.Iit may present as polyp,friable exophytic mass to 
endophytic lesions. Small basaloid cells are arranged  as sheets,nests,trabeculae 
and cords. It presents with cribriform pattern with basement membrane like 
eosinophilic hyaline material or mucin or secretions which are eosinophilic with 
variable mitotic activity and necrosis. Hyalinization or myxoid or fibroblastic 
changes can be seen in the stroma. A solid variant is there in which there is 
absence of cribriform pattern . Diagnosis made with PAS positive basement 
membrane like material. This is an aggressive tumour. 
 Microcystic adenocarcinoma: Cystic pattern is seen. The patient usually present 
with vaginal bleeding and they may have mass or asymmetry of the cervix. 1 to 8 
mm sized cysts with eosinophili material is seen occupying 50 to 90% of the 
tumour. Lobular or diffuse cysts may be seen deep in the wall. Pseudostratified or 
cuboidal epithelium is seen with a fibrotic stroma. Typical endocervical 
carcinomatous areas are found within the tumour with mitosis.  
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Mesonephric adenocarcinoma and malignant mixed mesonephric tumours: 
These rare tumours have mesonephric duct remnants. The malignant mixed 
mesonephric tumour have heterologous or homologous sarcomatous areas . They 
present in age group 34 to 84 years who present with grossly visible lesion or 
bleeding. They present as polyp or cervical wall is enlarged diffusely. The 
adenocarcinomatous component occur in various patterns - tubular, 
glandular(ductal),solid,retiform and sex cord like. These cuboidal or columnar 
cells have moderate pleomorphism and mitosis is variable. The luminal spaces are 
filled with eosinophilic material and papillary structures. Spindle cells(non 
malignant) may be seen in biphasic cases. Other heterologous elements are also 
described. 
 
 
 
 
 
 
 
 
 
81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
82 
 
MASTER CHART 
 
S.NO PSP 
NO 
AGE/SEX OP NO PAP LBC HPE 
1. 16/15 28/F 5500497 ASC LSIL CC 
2. 17/15 30/F 5500306 N N LSIL 
3. 18/15 29/F 5500502 N N CC 
4. 20/15 40/F 5500632 N LSIL LSIL 
5. 21/15 30/F 5500381 N N CC 
6. 22/15 47/F 5503603 ASC ASC CC 
7. 23/15 65/F 5500323 HSIL SCC SCC 
8. 24/15 44/F 5503687 ASC ASC CC 
9. 26/15 27/F 5500578 N N CC 
10. 27/15 38/F 5500617 US LSIL HSIL 
11. 31/15 40/F 5508140 ASC N CC 
12. 32/15 38/F 5502052 N LSIL CC 
13. 37/15 40/F 5562073 N N CC 
14. 41/15 38/F 5502098 US US SCC 
15. 43/15 42/F 5508239 LSIL LSIL LSIL 
16. 45/15 35/F 5500382 N N CC 
17. 46/15 37/F 5500397 ASC ASC LSIL 
18. 53/15 40/F 5502063 N N CC 
19. 56/15 40/F 5508363 N N CC 
20. 58/15 32/F 0000647 N N CC 
21. 59/15 35/F 0000737 N LSIL LSIL 
22. 62/15 36/F 5500476 N N CC 
23. 64/15 35/F 104063 N N CC 
24. 65/15 50/F 870 LSIL N CC 
25. 67/15 47/F 55608463 LSIL N CC 
26. 68/15 35/F 5500478 N N CC 
27. 74/15 42/F 66134 N HSIL CC 
28. 77/15 37/F 5500527 N N CC 
29. 83/15 34/F 0001493 N N CC 
30. 85/15 37/F 5504777 N N CC 
31. 87/15 42/F 5500611 N N CC 
32. 88/15 50/F 0001198 N N CC 
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33. 94/15 35/F 0003672 US US SCC 
34. 99/15 32/F 1095 N N CC 
35. 101/15 35/F 957 N N CC 
36. 105/15 40/F 3443 N N CC 
37. 110/15 41/F 3644 N N CC 
38. 111/15 32/F 3519 N N CC 
39. 112/15 41/F 1458 N N CC 
40. 114/15 42/F 3488 N N CC 
41. 116/15 37/F 3494 N N CC 
42. 199/15 47/F 13812 N N CC 
43. 203/15 43/F 14270 N N CC 
44. 204/15 49/F 1092 N N CC 
45. 207/15 52/F 351281 LSIL HSIL SCC 
46. 214/15 30/F 17742 N N CC 
47. 224/15 41/F 17658 ASC HSIL HSIL 
48 225/15 29/F 335801 N N  LSIL 
49. 226/15 47/F 17663 N N CC 
50. 227/15 27/F 17670 N N CC 
51. 231/15 35/F 17651 N N CC 
52. 232/15 35/F 14045 N N CC 
53. 245/15 42/F 17901 LSIL LSIL LSIL 
54. 246/15 45/F 17789 N N CC 
55. 247/15 45/F 371256 N N CC 
56. 248/15 46/F 14258 N N CC 
57. 257/15 35/F 3672 US US SCC 
58. 259/15 30/F 17944 N N CC 
59. 261/15 49/F 17916 N N CC 
60. 262/15 35/F 17955 N N CC 
61. 263/15 30/F 17939 N N CC 
62. 264/15 40/F 3443 N N CC 
63. 265/15 35/F 17929 N N CC 
64. 268/15 35/F 7952 N LSIL CC 
65. 271/15 40/F 352013 N N CC 
66. 272/15 45/F 18133 N N CC 
67. 276/15 40/F 18145 ASC N CC 
68. 278/15 40/F 18059 N N CC 
69. 280/15 39/F 17773 N N CC 
70. 281/15 33/F 9347 N N CC 
71. 282/15 30/F 9344 N N CC 
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72. 283/15 45/F 14207 N N CC 
73. 284/15 45/F 14040 ASC ASC CC 
74. 286/15 43/F 9272 US N LSIL 
75. 290/15 50/F 121095 N N CC 
76. 291/15 45/F 6071 N HSIL CC 
77. 292/15 35/F 9612 N LSIL LSIL 
78. 293/15 46/F 17957 ASC ASC CC 
79. 294/15 43/F 9491 ASC HSIL HSIL 
80. 298/15 37/F 9431 ASC ASC LSIL 
81. 302/15 35/F 376693 N LSIL LSIL 
82. 303/15 42/F 9570 LSIL N  CC 
83. 306/15 35/F 9677 US US SCC 
84. 308/15 37/F 353052 N N CC 
85. 310/15 34/F 9642 US LSIL HSIL 
86. 311/15 60/F 786 HSIL SCC POORLY 
DIFFERENTI-
-ATED SCC 
87. 314/15 35/F 9694 N HSIL HSIL 
88. 356/15 55/F 14133 N N CC 
89. 372/15 62/F 38203 LSIL HSIL SCC 
90. 375/15 31/F 30523 N N CC 
91. 385/15 25/F 41570 ASC LSIL CC 
92. 389/15 36/F 30500 N N CC 
93. 392/15 38/F 38183 N N CC 
94. 402/15 33/F 38201 N N CC 
95. 407/15 37/F 41616 N N CC 
96. 409/15 49/F 37570 LSIL N CC 
97. 417/15 40/F 37791 N N CC 
98. 439/15 67/F 52049 N N CC 
99. 451/15 40/F 48569 N HSIL HSIL 
100. 452/15 45/F 355301 US N LSIL 
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OBSERVATION AND RESULTS 
This prospective study was conducted on 100 patients who attended the pilot 
screening project programme being organized by Tamilnadu health screening 
project conducted at the department of Obstetrics and Gynaecology,Raja 
Mirasudar hospital affiliated to Thanjavur medical college,Thanjavur. 
Clinical history regarding age, socioeconomic status, parity and complaints 
were obtained from the patient, and thorough physical examination was done. Per 
speculum examination was done. Exfoliative cytology specimens were collected 
for conventional PAP smear and Liquid based cytology. Colposcopy was done 
using Sim’s speculum and biopsy was taken from the same patient. 
Most of the cases who attended the screening programme were in the fourth 
decade of life(50 cases , 50%) followed by 32 cases(32%) in the fifth decade. 
Minimum age of the patient screened was 25 years of age and the maximum age 
was 67 years. About 61.5% of cases who was diagnosed with LSIL and HSIL were 
in the age group of 21 – 40 years. Age wise distribution of cases are shown in table 
3 and chart 1. 
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TABLE 3: Age wise distribution of cases: 
AGE TOTAL NORMAL ABNORMAL LSIL HSIL CARCINOMA 
25-30 12 10 2 2 - - 
31-35 24 16 8 3 2 3 
36-40 26 20 6 3 2 1 
41-45 20 14 6 4 2 - 
46-50 12 12 - - - - 
51-55 2 1 1 - - 1 
56-60 1 - 1 - - 1 
>60 3 1 2 - - 2 
TOTAL 100 74 26    
 
   Out of 100 cases,36 cases(36%) of  cases belonged to class II of modified 
Prasad’s classification82 followed by 24 cases(24%) of cases in class III. Out of 26 
cases with dysplasia/carcinoma, 12 cases (46.1 % ) of cases belonged to class 
III.(Table 4 & chart 2) 
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Chart 1: Age wise distribution of cases
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TABLE 4: Case distribution according to socio-economic status ( Modified 
prasad’s classification)82 
Class(rupees) Total no. of cases Normal cases Abnormal cases 
I( 5571 & above) 10 10 - 
II(2786 – 5570) 36 28 8 
III(1671- 2785) 24 12 12 
IV(836 – 1670) 12 10 2 
V(Below 836) 18 14 4 
Total 100 74 26 
 
90 cases(90%) started sexual activity before 25 years of age and out of these 90 
patients,92.3% had dysplasia but out of the remaining 10 cases,only 2 cases(2% of 
total number of cases) showed dysplasia. (Table 5). 
Table 5: Case distribution according to the onset of sexual activity: 
Age Total number of cases % of patients with 
dysplasia 
<25 years 90 92.3%  of 90 cases 
>25 years 10 2% of 100 cases 
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Chart 2: Case distribution according to Socioeconomic status 
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 In this study, about 46 cases (46%) had 2 children and 34 cases (34%) had 3 
children. Most of the cases with dysplasia were seen when patients had 3 
children(14 cases , 53.8% of the abnormal smears)( Table 6 & chart 3). 
 
Table 6: Case distribution according to parity: 
Gravida Total number of cases Number of cases with 
dysplasia 
Nulligravida 6 2(2%) 
1 8 - 
2 46 7(7%) 
3 34 14(14%) 
>3 6 3(3%) 
 
Most common presenting complaint was white discharge per vaginum (46 
cases,46%),followed by lower abdominal pain(26 cases,26%) and bleeding per 
vaginum(16 cases,16%).other minor complaints were dysfunctional uterine 
bleeding(4 cases,4%),itching(4 cases,4%),difficulty in micturition(2 cases,2%),post 
coital bleeding(2 cases,2%).(Table 7 & chart 4). 
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Chart 3:  Case distribution according to parity 
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Table 7: Case distribution according to the presenting complaints: 
Complaints Number  of cases 
White discharge P/V 46 cases (46%) 
Lower abdominal pain 26 cases (26%) 
Bleeding P/V 16 cases (16%) 
Dysfunctional uterine 
bleeding 
4 cases (4%) 
Dfficulty in micturition 2 cases (2%) 
Post coital bleeding 2 cases (2%) 
 
Out of the 100 cases studied, conventional PAP smear detected abnormality 
in 22 cases(22%) whereas LBC detected abnormality in 28 cases(28%) of cases.( 
Table 8 & chart 5) 
Table 8: number of abnormal cases 
Study Abnormal cases 
Conventional PAP 22(22%) 
LBC 28(28%) 
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Chart 4: Case distribution according to presenting complaints 
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Chart 5: Number of abnormal cases 
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Out of the 100 cases , 92 cases(92%) were satisfactory for evaluation in 
conventional PAP smear whereas 96 cases(96%) were satisfactory in LBC. About 
60 cases(60%) in conventional PAP smear and 12 cases(12%) were satisfactory but 
limited by factors such as blood and inflammatory cells, air drying. 8 cases(8%) 
and 4 cases(4%) were unsatisfactory. The most common cause for 
unsatisfactoriness in conventional PAP smear is thick smear and reduced cell 
number in LBC.  Table 9 & chart 6 shows the comparison of  results of both 
Conventional PAP and LBC. 
TABLE 9:  comparison of PAP and LBC results 
Category PAP( 
number) 
PAP (%) LBC(number) LBC (%) 
Unsatisfactory 8 8% 4 4% 
Normal 70 70% 68 68% 
ASC 12 12% 6 6% 
LSIL 8 8% 12 12% 
HSIL 2 2% 8 8% 
Carcinoma - - 2 2% 
Total 100 100% 100 100% 
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Chart 6: Comparison of Conventional PAP and LBC results 
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Chart 7: Results of Conventional PAP smear 
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Chart 9: Results of biopsy specimens. 
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A comparative study between the findings of conventional PAP smear and 
the biopsy results were made. Out of 100 cases 92 cases were satisfactory for 
evaluation. Out of the 92 cases,70 cases were found to be normal. Out of the 70 
normal cases in PAP, 62 cases had normal histology in the biopsy obtained, 6 cases 
had LSIL changes and 2 cases had HSIL change histopathologically. Atypical 
squamous cells(ASC) were found in 12 cases in PAP. Out of 12 ASC cases in 
PAP,8 had normal histology,2 cases each had LSIL change and HSIL change in 
biopsy. 8 cases had LSIL features in conventional PAP smear. Out of these 8 
cases,4 cases had normal histology and 2 case had LSIL features and  carcinoma 
was found in 2 cases histopathologically. 2 cases showed HSIL features in PAP 
which turned out to be carcinoma histopathologcally. Results of PAP smear is 
shown in chart 7 and its correlation with histopathology is shown in table 10. 
TABLE 10: Comparison of  conventional PAP and histopathology results: 
HPE 
PAP 
PAP 
results 
Normal LSIL HSIL Carcinoma 
Unsatisfactory 8 - 2 2 4 
Normal 70 62 6 2 - 
ASC 12 8 2 2 - 
LSIL 8 4 2 - 2 
HSIL 2 - - - 2 
Carcinoma - - - - - 
Total 100 74 12 6 8 
Similarly, comparative study was also found between LBC and biopsy 
results. 96 cases were found to be satisfactory for evaluation. Out of the 96 
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cases,68 cases were found to be normal. Out of the 68 normal cases, 64 cases also 
had normal histology on biopsy, 4 cases had LSIL features. 6 cases had atypical 
squamous cells in LBC, but out of these , 4 cases had normal histology and 2 cases 
had LSIL features on histopathology. 12 cases had LSIL features on LBC and out 
of the 12 cases, 4 cases had normal histology,6 cases also had LSIL features and 2 
cases had HSIL features in histopathology. 8 cases had HSIL features on LBC. Out 
of the 8 cases, 2  cases  had normal histology,4 cases had HSIL features and 2 
cases had carcinoma. 2 cases which had carcinoma on LBC also had similar 
features in biopsy. The results of LBC are shown in chart 8 and its comparison 
with HPE is shown in table 11. 
TABLE 11: Comparison of  LBC and HPE results 
HPE 
LBC 
LBC 
results 
Normal LSIL HSIL Carcinoma 
Unsatisfactory 2 - - - 2 
Normal 34 32 2 - - 
ASC 3 2 1 - - 
LSIL 6 2 3 1 - 
HSIL 4 1 - 2 1 
Carcinoma 1 - - - 1 
Total 50 37 6 3 4 
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 Statistics: 
Sensitivity  and specificity of PAP smear in detecting LSIL: 
PAP 
       HPE 
POSITIVE NEGATIVE 
POSITIVE 4( TP) 4(FP) 
NEGATIVE 6(FN) 62(TN) 
Sensitvity = TP /TP + FN x 100 = 4/4+6 x 100 = 40 % 
Specificity = TN/TN + FP x 100 = 62/ 62 + 4 x 100 = 93% 
Sensitivity and specificity of PAP smear in detecting HSIL: 
PAP 
       HPE 
POSITIVE NEGATIVE 
POSITIVE 2( TP) 0(FP) 
NEGATIVE 6(FN) 62(TN) 
Sensitivity = TP /TP + FN x 100 = 2/2+2 x 100 = 50% 
Specificity = TN/TN + FP x 100 = 62/ 62 + 0 x 100 = 100% 
Sensitivity and specificity of LBC in detecting LSIL: 
LBC 
       HPE 
POSITIVE NEGATIVE 
POSITIVE 8( TP) 4(FP) 
NEGATIVE 4(FN) 64(TN) 
 
Sensitvity = TP /TP + FN x 100 = 8/8+4 x 100 = 66% 
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Specificity = TN/TN + FP x 100 = 64/ 64 + 4 x 100 = 94% 
Sensitivity and specificity of LBC in detecting HSIL: 
LBC 
       HPE 
POSITIVE NEGATIVE 
POSITIVE 6( TP) 2(FP) 
NEGATIVE 0(FN) 64(TN) 
Sensitvity = TP /TP + FN x 100 = 6/6+0 x 100 = 100% 
Specificity = TN/TN + FP x 100 = 64/ 64 + 2 x 100 = 96% 
Sensitivity and specificity of LBC in detecting carcinoma: 
LBC 
       HPE 
POSITIVE NEGATIVE 
POSITIVE 2( TP) 0(FP) 
NEGATIVE 0(FN) 64(TN) 
Sensitvity = TP /TP + FN x 100 = 2/2+0 x 100 = 100% 
Specificity = TN/TN + FP x 100 = 64/ 64 + 0 x 100 = 100% 
Overall sensitivity and sensitivity of  PAP smear: 
PAP 
       HPE 
POSITIVE NEGATIVE 
POSITIVE 10( TP) 6(FP) 
NEGATIVE 8(FN) 62(TN) 
 
Sensitvity = TP /TP + FN x 100 = 5/5+4 x 100 = 55.5% 
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Specificity = TN/TN + FP x 100 = 62/ 62 + 6 x 100 = 83.7% 
Overall sensitivity and specificity of LBC: 
LBC 
       HPE 
POSITIVE NEGATIVE 
POSITIVE 20( TP) 10(FP) 
NEGATIVE 4(FN) 64(TN) 
Sensitvity = TP /TP + FN x 100 = 20/20+4 x 100 = 83% 
Specificity = TN/TN + FP x 100 = 64/ 64 + 10 x 100 = 86.5% 
STATISTICAL CORRELATION 
Controlling for Age Factor partial correlation co-efficient shows: 
1. The LBC Vs HPE  ( r = 0.617)  - High level of correlation 
2.  LBC Vs Papsmear  (r= 0.59) – Medium level of correlation  
3. Papsmear Vs HPE (r = 0.4651) – Medium level of correlation. 
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DISCUSSION 
For more than 50 years, PAP smear remained the only modality for 
screening which had a high false positive rate. Due to this, liquid based cytology 
was developed. This study was done to compare both the methods by correlating it 
with the biopsy taken from the same patient. 
100 patients were randomly selected from those attending the Pilot screening 
project conducted at the Department of Obstetrics and Gynaecology, Thanjavur 
medical college for the study and all the three samples were taken from all the 
cases and the results analysed. 
Out of the 100 cases, 50 cases (50%) of cases were in the fourth decade of 
life and most of the LSIL and HSIL cases were in the 4
th 
decade ,a finding similar 
to Sherwani RK et al.
83
, Richart et al.,
84
,Jie Zhu et al.,
98
 , Erdin ITLER et al.,
92  
,Dr. 
Shubhangi et al.,
114
, Macharid H.C et al
118
, M.Almonte et al.,
121.
 . But studies by 
Ahmed Ibrahim
123
 , Chinaka et al.
120
, and S.E Nigerio Justus et al.
112
, reported 
cases mostly in the 5
th
 decade of life which in contrast to a study by Pragya Sharma 
et al.
113
, who reported most number of cases in the 3
rd
 decade of life.Invasive 
cancer was diagnosed in 35 years of age in our study which was similar to that of 
Sherwani RK et al.
83
, but contrast to Parker et al.
85 
who reported carcinomas above 
the age of 70 years. Early marriage and early sexual activity in this part of the 
119 
 
country may be responsible for the early onset of invasive cancer. Age with 
maximum dysplasia is shown in table 12 and chart 10. 
Table 12 : Studies showing their ages with maximum dysplasia: 
Studies Decade with maximum dysplasia 
This study 4
th 
decade 
Sherwani RK et al.
83
 4
th 
decade 
Richart et al.,
84
 4
th 
decade 
Jie Zhu et al,
98
 4
th
 decade 
Erdin ITLER et al.,
92
 4
th
 decade 
Dr. Shubhangi et al.,
114
 4
th
 decade 
Macharid H.C et al.,
118
 4
th
 decade 
M.Almonte et al., 
121
 4
th
 decade 
Ahmed Ibrahim 
123
 5
th
 decade 
Chinaka et al.,
120
 5
th
 decade 
S.E Nigerio Justus et al.,
112
 5
th
 decade 
Pragya Sharma et al.,
113
 3
rd
 decade 
Parker et al.
85
 >70 years 
About 46.1% of the abnormal smears belonged to class III socioeconomic status 
and most of the dysplasia cases were observed in this group which was similar to 
Sherwani RK et al.,
83
 and Christopherson and Parker 
89
,Pragya Sharma
113
 . Parker 
noted that lower socio economic status women had marriage at a younger  
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Chart 10 : showing decade with maximum dysplasia. 
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age and child birth. Latest WHO report shows that 70% of cases are from the lower 
socio economic status due to lack of access to screening programs and late 
detection of diagnosis and treatment.
1
 . A thesis done by Ahmed Ibrahim
123
., 
showed that uneducated and unemployed from the lower socioeconomic status 
showed more dysplasia.  Also S.E. Nigerio Justus et al.
112
, postulated that 
illiteracy, poverty, nonuse of screening methods and lack of communication after 
referral among lower socio economic status persons were responsible for the 
increased number of dysplasia among these persons. 
Carcinoma and dysplasia were mostly diagnosed when the parity was 3 or 
more in this study (53.8% of abnormal smears) similar to Pragya Sharma
113
 and 
Dr.Shubanigi et al.,
114
.  M.Almonte et al.,
121
 reported more incidence of dysplasia 
when the parity was four. Sherwani RK et al
83
 and Shankaranarayana et al 
86
 
reported high incidence of dysplasia when the parity was more than five. Parker et 
al 
87
 showed four fold increase in incidence of dysplasia when the parity was seven 
or more similar to S.E Nigerio Justus et al.,
112
. Louise et al
13
 found a 5 fold 
increase in risk of dysplasia when the parity was 14 or more. This is shown in table 
13 and chart 11. 
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Table 13 : Studies showing parity with maximum dysplasia 
Studies Parity 
This study 3 
Pragya Sharma et al.,
113
 3 
Dr.Shubhanigi et al.,
114
 3 
M.Almonte et al., 
121
 4 
Sherwani RK et al
83
 5 
Shankaranarayana et al 
86
 5 
S.E.Nigerio Justus et l., 
112
 7 
Parker et al 
87
 7 
Louise et al
13
 14 
 
About 90%(90 cases) of cases in this study had onset of sexual activity 
before 25 years of age where majority of dysplasia was noted. Only 2  patients 
with the start of sexual activity above the age of 25 years had dysplasia. This 
finding was similar to Sherwani RK et al.,
83
 and Rotkin et al.,
88
. Rotkin postulated 
that during intercourse, there is higher probability of transmission of infections and 
hence dysplasia is more common when there is early onset of sexual activity.
88
 S.E 
Nigerio Justus et al., 
112
 and Pragya Sharma et al., 
113 
also postulated that early  
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Chart 11 :   studies showing parities with maximum dysplasia 
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marriage and early onset of sexual activity were responsible for increased 
dysplasia. 
Most of our cases complained of white discharge PV (46 cases,46%) 
followed by lower abdominal pain and bleeding PV(26 cases (26%) and 16 
cases(16%) respectively). Sherwani et al 
83
 , Kenneth and Yao 
90
 , S.E Nigerio 
Justus et al., 
112 
,Pragya Sharma et al.,
113
 and Dr.Shubhanigi et al., 
114
 also had 
patients with similar complaints. Kenneth and Yao noted that white discharge was 
associated with neoplastic changes in cervix similar to our study where most of the 
dysplastic changes were in this subset of patients. In a study done by Robert ME et 
al., 
91
 Post coital bleeding was noted in many patients and all these had 
dysplasia(66.7%) and carcinoma (33.3%) . In contrast, only 2 cases in this study 
had this complaint and similar to Robert ME et al
91
  this patient had carcinoma. 
Study done by M.Tarney et al .,
121
, also had more number of patients with 
complaints of post coital bleeding in contrast to our study.(table 14) 
Table 14 :  studies and their most common complaints 
Studies Most common complaint 
This study White discharge P/V 
Sherwani et al 
83
 White discharge P/V 
Kenneth and Yao 
90
 White discharge P/V 
S.E. Nigerio Justus et al., 
112
 White discharge P/V 
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Pragya Sharma et al., 
113
 White discharge P/V 
Dr.Shubanigi et al., 
114
 White discharge P/V 
M.Tarney et al., 
121
 Post coital bleeding 
Robert ME et al.,
91
 Post coital bleeding   
In our study, the number of satisfactory smears  were 92%(92 cases) in 
Conventional PAP smear compared to(96 cases) 96% in Liquid based cytology. 
Most of the unsatisfactory smears in conventional PAP were due to thick and 
bloody smears whereas in LBC, it is due to reduced cell number.  Percentages of 
satisfactory smears in other studies are shown in Table 15 and chart 12. 
Table 15: studies and their percentage of satisfactory smears 
 Conventional 
PAP(%) 
LBC(%) 
This study 92 96 
Erdin ITLER et al.,
92
 99.50 99.95 
Beerman et al.,
93
 99.1 99.87 
Monsonego et al.,
94
 99.52 99.47 
Sykes et al.,
95
 97.3 98.9 
Longatto et al,
96
 89.6 98.6 
Weintraub and Morabia et al.,
97
 72.2 92 
Sherwani RK et al.,
83
 31.9 83.1 
Chinaka et al., 
120
 53.3 83.3 
Guidelines for use of LBC in 
cervical cancer screening 
117
 
90.9 98.4 
126 
 
GP notebook 
119
 91 98.6 
M.Almonte et al., 
121
 88.6 94.5 
Singh VB et al., 
116
 95.7 98.3 
In all these studies, liquid based cytology had more number of satisfactory 
smears than the conventional PAP smear. In our study, the reason for 
unsatisfactoriness in conventional PAP smear is thick smear and obscuring blood 
and inflammatory cells and LBC is reduced number of cells similar to Monsanego 
et al.,
94
. According to Sherwani et al.,
83
 in Liquid based cytology cytolysis and 
drying artifact is minimal or absent due to immediate fixative in a liquid fixative 
and lesser limited factors such as inflammatory cells, blood and mucus and in 
Conventional PAP is due to thick smear. 
In the present study , number of ASC cases in CP was 12%(12 cases) and 
6% in LBC(6 cases). The number of ASC cases in other studies are shown in table 
16 and chart 13: 
Table 16 : studies with their percentage of atypical squamous cells  
Studies CP(%) LBC(%) 
This study 12 6 
Davey et al., 
131
 3.8 4 
ERDIN itler et al., 
92
 2.1 2.6 
Jie Zhu et al., 
98
 8 4 
O Abulafia et al., 
55
 7.35 8.31 
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Bolick et al., 
103
 2.42 2.97 
Diaz –Rosario et al., 99 4.76 4.53 
Weintraub et al., 
97
 1.50 2.40 
Hatch et al., 
111
 7.04 8 
Guidos et al., 
110
 2.03 3.40 
The number of smears diagnosed as ASC was more in Conventional PAP 
smear (12 cases,12%)  compared to Liquid based cytology(6 cases,6%) similar to 
that of Jie Zhu et al
98
 and Diaz Rosario et al., 
99 
but contrast to studies by Davey et 
al, 
131 
, ERDIN itler et al., 
92
 ,Jie Zhu et al., 
98
 , O Abulafia et al., 
55
 , Bolick et al., 
103
 , Weintraub et al., 
97
 , Hatch et al., 
111
 , Guidos et al., 
110
 who showed that LBC 
was a better test for diagnosis of ASC. 
In the present study number of  LSIL increased from 8% in Conventional 
PAP to 12% in LBC. Other studies with similar results are shown in table 17 and 
chart 14: 
Table 17 : studies with their percentage of LSIL cases 
 Conventional PAP(%) LBC(%) 
This study 8 12 
Sherwani RK et al
83
 10.6 18.1 
Hutchinson et al 1992
48
 9 10.6 
Diaz-Rosario and Kabawat et al
99
 1.6 2.7 
Beerman et al 
93
 0.22 0.27 
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Monsonego et al 
94
 1.2 1.84 
Hutchinson et al 1999
100
 3.03 3.40 
Jie Zhu et al 
98
 29 32 
Sykes et al 
95
 21 24.4 
O.Abulafia et al 
55
 6.24 7.15 
M.Almonte et al., 
121
 0.9 13.8 
Chinaka et al., 
120
 10.6 12.6 
  In all these studies, it can be seen that the rate of detection of LSIL is higher 
in LBC than Conventional PAP smears.  
In our present study, rate of detection of  HSIL was more with LBC( 6 cases, 
6%) compared to that of Conventional PAP(2 cases, 2%).Many studies have found 
similar results and these are shown in table 18 and chart 15. 
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Table 18 : studies with their percentage of HSIL cases 
 Conventional PAP(%) LBC(%) 
My study 2 6 
Sherwani RK et al 
83
 0.6 4.3 
Diaz-Rosario and Kabawat et al
99
 0.3 0.5 
Beerman et al
93
 0.56 0.64 
Monsonego et al 
94
 0.52 0.60 
Hutchinson et al 1999
100
 1.54 1.60 
O.Abulafia et al 
55
 4.24 4.45 
M.Almonte et al., 
121
 0.9 3.1 
Chinaka et al., 
120
 8.0 10.0 
Similar to LSIL, LBC detected more HSIL lesions than conventional PAP 
smear.  
In our study,1 frank carcinoma was detected in LBC, whereas no case were 
detected in Conventional PAP because the carcinoma cases in Conventional PAP 
smears were bloody and hence unsatisfactory for evaluation. In contrast to our 
study, Beerman et al.
93
, Hutchinson et al.
100
,Sykes et al.
95
, O.Abulafia et al 
55
 
reported higher detection of carcinoma in Conventional PAP than LBC. 
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Chart 12: studies showing percentage of satisfactory smears 
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Chart 13: studies with their percentage of atypical squamous cells. 
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Chart 14: studies with their percentage of LSIL cases 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
Conventional PAP(%)
LBC(%)
133 
 
 
 
  Chart 15 : studies with their percentage of HSIL cases.. 
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Concordance between CP and LBC: 
This study showed 84% concordance between Conventional PAP and LBC. 
Quite similarly, Hussein et al 
101
 showed 73% agreement and O.Abulafia et al 
55
 
study, which is a comparison of 17 paired studies showed in general 90% 
concordance and 10% discordance. He showed that in various studies, discordance 
was as low as 1% and as high as 20%. 
Concordance with histological findings: 
Sensitivity: 
Sensitivity of the screening tests in detecting low grade SIL: 
Our study showed sensitivity of 40% in CP and 66% n LBC for detecting 
LSIL. Sensitivity of other studies are shown in table 19 and chart 16. 
Table 19: Sensitivity of the screening tests in various studies in detecting low 
grade SIL 
Studies CP(%) LBC (%) 
This study 40 66 
Lee K C et al., 
124
 62.6 91.7 
Kim Y R et al., 
125
 64 86 
Jeon Y K et al., 
126
 73.7 78.9 
Lim Y K et al., 
127
 87.2 94.9 
Park IA et al., 
128
 89.6 82.8 
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Arbyn et al., 
122
 75.6 79.1 
ERDIN Itler et al., 
92
 37.5 54.5 
M.Almonte et al., 
121
 26.21 69.66 
Except for a study done by Park IA et al., 
128 
, in all the other studies LBC 
was more sensitive than CP in detecting LSIL. 
Sensitivity of the screening tests in detecting high grade SIL: 
Our study showed sensitivity of 50% in CP and 100% in LBC. Sensitivity of 
other studies is shown in table 20 and chart 17. 
Table 20 : Sensitivity of the screening tests in various studies in detecting high 
grade SIL 
Studies CP(%) LBC(%) 
This study 50 100 
Lee K C et al., 
129
 62 85.1 
Jim K Young oh et al., 
130
 76 92 
Arbyn et al., 
122
 55.2 57.1 
ERDIN itler et al., 
92
 50 61 
Jie Zhu et al., 
98
 47 66 
  In all these studies, LBC was a better test for diagnosing HSIL lesions. 
 
 
 
136 
 
 
 
 
 
Chart 16 : Sensitivity of the screening tests in various studies in detecting low grade SIL: 
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Chart 17 :Sensitivity of the screening tests in various studies in detecting high grade SIL: 
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Overall sensitivity: 
Our study showed sensitivity of 55.5% in CP and 83% in LBC. Sensitivity 
of other studies are shown in table 21 and chart 18. 
Table 21 : Overall sensitivity of the screening tests in various studies 
 Conventional PAP(%) LBC(%) 
My study 55.5 83 
O.Abulafia et al 
55
 68 76 
Sykes et al 
95
 73.7 79.1 
Mojgan Karimi Zarchi et al 
102
 51 55.3 
Bolick et al 
103
 85 95 
Hussein et al 
101
 83 92 
Sherwan RK et al 
83
 53.7 97.6 
Chinaka et al., 
120
 86 100 
Sheets et al.
104
, Sherman et al 1997 
105
,Roberts et al 1997 
106
, Papillo et al98 
107
,Sherman et al 1998 
108
 , yeoh et al99 
109
, also showed higher sensitivity for LBC 
than CP and higher dectection rate similar to our study. O.Abulafia et al 
55 
compared 10 studies and showed that most of the studies had higher sensitivity for 
LBC and wide range of sensitivity (50%-90%). 
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Chart 18 : overall sensitivity of screening tests in various studies 
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Specificity: 
Specificity of the screening tests for detection of LSIL: 
Our study showed specificity of 93% for CP and 94% for LBC. Specificity 
of other studies are shown in table 22 and chart 19 
Table 22: Specificity of the screening tests for detection of LSIL in various 
studies                      
Studies CP(%) LBC(%) 
This study 93 94 
Lee K C et al., 
124
 96.1 75.9 
Kim Y R et al., 
125
 79.5 66 
Jeon Y K et al., 
126
 90.9 81.6 
Lim Y K et al., 
127
 87.2 92.3 
Park IA et al., 
128
 69.8 83 
Arbyn et al., 
122
 81.2 78.8 
  Our study showed increased specificity for LBC than CP similar to studies 
done by Lim YK et al., 
127
 and Park IA et al., 
128
 but contrast to Lee KC et al.,
124
 , 
Kim YR et al., 
125
 ,Jeon YK et al., 
126
 and Arbyn et al., 
122 
who showed that CP is 
more specific than LBC. 
Specificity of the screening tests for detection of HSIL: 
This study showed specificity of 100% for CP and 96% for LBC. Specificity 
of other studies are shown in table 23 and chart 20. 
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Table 23 : Specificity of the screening tests for detection of HSIL in various 
studies 
Studies CP(%) LBC(%) 
This study 100 96 
Lee KC et al., 
129
 96.5 98.3 
Jim K Young oh et al. 
130
 
76 79 
Arbyn et al.,
 122
 96.7 97 
 In contrast with other studies, our study showed that CP was more specific 
than LBC in detection of HSIL. 
Overall specificity: 
Our study showed specificity of 83.7% and 86.5% in CP and LBC 
respectively. Specificites of other studies are shown in table 24 and chart 21. 
Table 24 :Overall specificity of screening tests in various studies 
 Conventional PAP(%) LBC(%) 
My study 83.7 86.5 
O.Abulafia et al 
55
 79 86 
Sykes et al
95
 69 69 
Mojgan Karimi Zarchi et al 
102
 66 77.7 
Bolick et al 
103
 36 58 
Sherwan RK et al 
83
 50 50 
Chinaka et al., 
120
 97 100 
Macharid et al., 
118
 11 75 
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Other studies which shows higher specificity of LBC Sheets et al.
104
, 
Sherman et al 1997
105
,Roberts et al 1997 
106
 , Papillo et al 98 
107
 ,Sherman et al 
1998 
108
 , yeoh et al99 
109
, Guidos et al 1995
110
,Hatch et al 00 
111
,Park et al2001 
56 
Chinaka et al.,
120
 , Macharid et al.,
118
 similar to our study. But a study done by 
Hussein et al.,
101
 showed high specificity for CP(82% vs & 76%). 
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Chart 19 : Specificity of the screening tests for detection of LSIL in various studies:      
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Chart 20 :Specificity of the screening tests for detection of HSIL in various studies: 
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Chart 21 : Overall specificity of screening tests in various studies: 
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SUMMARY AND CONCLUSION 
  This study was conducted to compare the efficacy of CP and LBC in 
detecting intraepithelial lesions by comparing with the biopsy result which is 
considered the gold standard. 
The results of the study is as follows: 
1. 50% of cases who attended the screening program were in the fourth decade 
of life and LSIL and HSIL cases were mostly in the age group of 21-40 
years of age. 
2. Out of 90% cases who started sexual activity before 25 years of age, 92.3% 
cases showed dysplasia. 
3. 46% of cases had parity 2. Dysplasia was reported more in cases when the 
parity was more than 3 (53.8% of the abnormal smears).  
4. Most of the cases(36%) were in the class II of modified Prasad 
classification.46.1% of the 13 cases with dysplasia were in the class III of 
modified Prasad classification. 
5. About 46% of the cases presented with white discharge per vaginum. 
6. LBC detected abnormality in 28% of cases whereas CP detected in only 
22% of cases. 
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7. 96% of cases were satisfactory for evaluation in LBC whereas 92% of cases 
were satisfactory in CP. 
8. ASC cases was detected more in CP than LBC(12% vs 6%) 
9. LSIL was detected more in LBC than CP( 12% in LBC vs 8% in CP ) 
10. HSIL was deteted more in LBC than CP ( 8% in LBC vs 2% in CP ) 
11.  LBC detected 1 case of carcinoma whereas none was detected in CP. 
12.  In our study, concordance between CP and LBC was 84% 
13. Sensitivity for detection of LSIL was more for LBC than CP(66% in LBC vs 
40% in PAP) 
14. Sensitivity for detection of HSIL is more for LBC than CP(50 % for CP vs 
100% for LBC) 
15. LBC was more specific than CP for detection of LSIL(93% for CP vs 94% 
for LBC) 
16. Specificity was more for CP than LBC for detection of HSIL cases(100% for 
CP vs 96% for CP) 
17.  Our study showed sensitivity of 55.5% in CP and 83% in LBC 
18. Our study showed specificity of 83.7% and 86.5% in CP and LBC 
respectively 
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19. Controlling for Age Factor The LBC Vs HPE level is highly correlated ( r = 
0.617),  LBC Vs PAP smear  (r= 0.59) and Medium level of Correlated level 
of PAP ssmear Vs HPE (r = 0.4651) 
So, the risk factors for the development of dysplasia according to our study 
is older age, early sexual activity, increasing parity and lower socio economic 
status. 
Though CP is a simple and cost effective method of cervical screening 
which has been in use for more than 50 years, false negative rate is an important 
disadvantage. To overcome this,LBC was developed in which obscuring materials 
such as blood and mucus was less ( which was more in CP ) and provided slides 
with a monolayer of well preserved cells which was easier to interpret. So, we 
compared both these methods in our study and compared it with the biopsy result. 
LBC provided more representative samples and morphology of the cells were 
better visualized due to less obscuring materials. LBC generated more number of 
satisfactory smears and intraepithelial lesions were detected more in LBC. 
Sensitivity and specificity was more in LBC than CP.  LBC showed better 
correlation with HPE than CP statistically. 
To conclude, in a country where more number of people belong to lower 
socio – economic status and with higher incidence of cervical cancer , screening 
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plays an important role in prevention . so awareness should be created about the 
screening programs and government should take adequate measures to improve the 
quality of the screening procedures by introducing improved methods like LBC, 
since cervical cancer is preventable by early detection and intervention. 
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APPENDIX I 
PROFORMA 
NAME: 
 
AGE:                                SEX: 
 
INCOME:                         WORK: 
 
AGE OF MENARCHE:                    AGE OF MARRIAGE:   
 
YEARS OF SEXUAL LIFE:               AGE OF MENOPAUSE: 
 
NO OF CHILDREN: 
 
        AGE OF FIRST CHILD BIRTH: 
        AGE OF LAST CHILD BIRTH: 
PRESENTING COMPLAINTS: 
        LOWER ABDOMINAL PAIN         YES/NO 
        SPOTTING                                         YES/NO 
        WHITE DISCHARGE                        YES/NO 
        DIFFICULTY IN MITURITION        YES/NO 
        POST COITAL BLEEDING               YES/NO 
        ITCHING                                            YES/NO 
        IRREGULAR PERIODS                    YES/NO 
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APPENDIX II 
RAPID PAP STAIN 
 
REQUIREMENTS: 
1. Harris haematoxylin 
2. EA and OG combo 
3. 100% alcohol 
 
PROCEDURE: 
1. Stain in harris haemotoxylin for 3 minutes 
2. Wash in 100% alcohol 
3. Rinse in running tap water for blueing for 5 minutes 
4. Stain in EA and OG combo for 3 minutes 
5. Wash in 100% alcohol – 3 times till all the stain is washed off. 
6. Dry the slides and mount with DPX. 
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APPENDIX III 
HAEMATOXYLIN AND EOSIN STAIN 
PREPARATION OF SOLUTION: 
HARRIS HAEMATOXYLIN: 
 Distilled water -1000ml 
 Ammonium alum – 100gm 
 Absolute ethyl alcohol – 50ml 
 Mercuric oxide – 2.5gm 
 100 gm of ammonium alum dissolved in 1000ml of distilled water by heating at 60 
degree centigrade. Add solution of 5 gm of haematoxylin in 50ml of ethylalcohol and 
bring rapidly to boil. When it begns to boil,remove from flame and add 2.5gm of 
mercuric oxide . Mix by swirling gently. 
EOSIN STAIN: 
 Eosin Y – 1gm 
 Distilled water – 20ml 
 95% ethanol – 80ml 
 Glacial acetic acid – 0.2ml 
 Dissolve 1gm of eosin Y in 20ml of water,then add 80ml of 95% ethylalcohol and 0.2ml 
of glacial acetic acid. 
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PROCEDURE: 
1. Bring the sections to water 
2. Dip in Harris haematoxylin for 15minutes 
3. Rinse in tap water 
4. Differentiate in 1% acid alcohol – 3-4 quick dips 
5. Wash in tap water briefly 
6. Dip in ammonia water or saturated lithium carbonate until the sections are blue. 
7. Wash in running tap water for 10-20 minutes 
8. Stain with eosin for 15seconds to 2 minutes depending on the age of the eosin and 
the depth of counter stain. 
9. Rinse in tap water. 
10. Dip in 95% alcohol. 
11. 3 changes in absolute alcohol. 
12. Xylene  - 2 changes. 
13. Mount in DPX mountant. 
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APPENDIX IV 
BETHESDA SYSTEM OF CLASSIFICATION (2001) 
The Bethesda System - 2001 
The Bethesda System-2001 consists of several components, as outlined below: 
SPECIMEN TYPE 
Indicate conventional (Pap smear) vs. liquid-based preparation versus other 
SPECIMEN ADEQUACY 
• Satisfactory for evaluation (describe presence or absence of endocervical or 
transformation zone component and other quality indicators, e.g., partially 
obscuring blood, inflammation, etc.) 
• Unsatisfactory for evaluation (specify reason) 
• Specimen rejected/not processed (specify reason) 
• Specimen processed and examined, but unsatisfactory for evaluation of 
epithelial abnormality because of (specify reason) 
GENERAL CATEGORIZATION (Optional) 
• Negative for Intraepithelial Lesion or Malignancy 
• Epithelial Cell Abnormality: See Interpretation/Result 
• Other: see Interpretation/Result (e.g. endometrial cells in a woman ≥40 yrs) 
INTERPRETATION/RESULT 
A. Negative for Intraepithelial Lesion or Malignancy 
When there is no cellular evidence of neoplasia, state this in the General 
Categorization above and/or in the Interpretation/Result section of the report 
–whether or not there are organisms or other non-neoplastic findings 
1. Organisms: 
• Trichomonas vaginalis. 
• Fungal organisms morphologically consistent with Candida spp 
• Shift in flora suggestive of bacterial vaginosis 
• Bacteria morphologically consistent with Actinomyces spp 
• Cellular changes consistent with herpes simplex virus 
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2. Other Non-neoplastic Findings (Optional to report; list not inclusive): 
• Reactive cellular changes associated with 
- inflammation (includes typical repair) 
- radiation 
- intrauterine device (IUD) 
• Glandular cells status posthysterectomy 
• Atrophy 
3. Other 
• Endometrial cells (in a woman ≥40 years of age) (specify if “negative for 
squamous intraepithelial lesion”) 
B. Epithelial Cell Abnormalities 
1. Squamous cell: 
• Atypical squamous cells 
- of undetermined significance (ASC-US) 
- cannot exclude HSIL (ASC-H) 
• Low-grade squamous intraepithelial lesion (LSIL) (encompassing: 
HPV/mild dysplasia/CIN1) 
• High-grade squamous intraepithelial lesion (HSIL)(encompassing: 
moderate and severe dysplasia, CIS, CIN 2 and CIN 3) with features 
suspicious for invasion (if invasion is suspected) 
• Squamous cell carcinoma 
3. Glandular Cell: 
• Atypical 
- endocervical cells (NOS or specify in comments) 
- endometrial cells (NOS or specify in comments) 
- glandular cells (NOS or specify in comments) 
• Atypical 
- endocervical cells, favor neoplastic 
- glandular cells, favor neoplastic 
• Endocervical adenocarcinoma in situ 
• Adenocarcinoma 
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- endocervical 
- endometrial 
- extrauterine 
- not otherwise specified (NOS) 
C. Other Malignant Neoplasm: (specify) 
ANCILLARY TESTING 
Provide a brief description of the test method(s) and report the result so that it is 
easily understood by the clinician. 
AUTOMATE REVIEW 
If specimen was examined by automated device, specify the device and the result. 
EDUCATIONAL NOTES AND SUGGESTIONS (optional) 
Suggestions should be concise and consistent with clinical follow-up guidelines 
published by professional organizations (references to relevant publications may 
be included). 
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APPENDIX V 
ANDERMANN ET AL  SCREENING CRITERIA. 
A.The Wilson jungner criteria for appraising the validity of a screening program: 
 The disease condition screened should be an important health problem 
 Natural history of the disease condition should be well understood 
 The disease should have an detectable early stage 
 Early stage diagnosis and treatment should have more benefits than treatment at a later stage 
 A suitable test should be developed for the early stage 
 The screening test should be acceptable by the population 
 The interval for repeating the test should be determined 
 Health care services should be made adequate for the extra clinical workload resulting from 
screening 
 Both physical and psychological risks should be less than the benefits 
 Financially, there should be a balance between the costs and benefits 
B. The criteria of screened condition 
 The disease condition should be an important health problem 
 The epidemiology and natural history of the disease, including development from latent 
to declared disease, should be adequately understood and there should be a detectable risk 
factor, disease marker, latent period or early symptomatic stage. 
 All the cost-effective primary prevention intervention should have been implemented as 
far as practicable 
 If the carriers of a mutation are identified as a result of screening the natural history of 
people with this status should be understood, including the psychological implications 
C. Criteria of screening test: 
 Screening test should be simple, safe, precise and validated 
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 The distribution of test values in the target population should be known and a suitable cutoff 
level defined and agreed 
 The screening test should be acceptable by the population 
 There should be an agreed policy on the further diagnostic investigation of individuals with a 
positive test result and on the choices available to those individuals 
If the screening test is done for mutations, the criteria to select the subset of mutations to be 
covered by screening, if all possible mutations are not being tested for, should be clearly set. 
D. The treatment for screened condition: 
 An effective treatment or intervention should be available for patients who are identified 
through early detection, with evidence that the early diagnosis and treatment will lead to 
better outcomes than late treatment 
 An evidence based policies should be there covering which individuals should be offered 
treatment and the appropriate treatment to be offered 
 All healthcare providers should be optimized about the clinical management of the condition 
and patient outcomes prior to participation in a screening program. 
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APPENDIX – VI 
UK NATIONAL SCREENING COMMITTEE
 
SCREENING PROGRAM. 
 High quality randomized control trials should have been conducted in the past to provide 
evidence that the mortality and morbidity is reduced by screening tests. Where the 
persons undergoing screening can get an informed choice about the screening procedure 
evidence must be there from the high quality trials that the screening procedure 
accurately measures risk. The information that is provided about the screening procedure 
must be of value and the information that is provided should be readily understood by the 
person undergoing screening. 
 Evidence should be there that the complete screening procedure is ethically, clinically 
and socially acceptable to the public and health care providers 
 The screening programs benefit should be more than the psychological and physical harm 
caused due to screening procedure, diagnostic test and the treatment given after the 
screening procedure 
 The expenditure for the screening program which will include testing, diagnosis 
,treatment, administration, training and quality assurance should be correctly balanced in 
relation to the cost of medical care as a whole 
 A plan for the monitoring and management of the screening procedure and a set of 
quality assurance standards. 
 The staffs and facilities required for the screening test, diagnosis, treatment and program 
management should be readily available before the commencement of the screening 
program. 
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 The other options available for managing the condition should be thought about before 
starting the screening program so that no more cost effective intervention is introduced or 
new intervention in the screening procedure is introduced within the available resources 
after the start of the screening program. 
 For assisting the participants in the screening program to make an informed choice, there 
should be an evidence based information about the potential consequences of testing, 
investigation and treatment 
 Public pressure for reducing the screening interval, for eligibility criteria widening and 
for sensitivity improvement of the screening test process should be anticipated. Decisions 
about the parameters should justified scientifically to the public. 
 The program should be acceptable to the people identified as carriers and to the family 
members if the screening test is done for identifying mutations. 
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APPENDIX – VII 
THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY SCREENING 
GUIDELINES FOR CERVICAL CANCER: 
 21 years should be the age at which screening should be started. 
 Screening periodicity – Now, annual screening is not recommended 
1. <21 years – screening is not recommended 
2. 21-29 years – cytology should be done every 3 years 
3. 30 to 64 years – every 3 years cytology alone is acceptable, contesting (HPV and 
cytology) every 5 years is preferred 
4. >65 years – if the patient has adequate prior negative screening, screening is not 
recommended 
5. After hysterectomy – screening is not necessary 
6. After HPV vaccination – screening as in unvaccinated women 
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